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Abstract 
Within this thesis are described synthetic approaches towards the 
phomactins which are novel platelet activating factor antagonists.  The work 
was carried out at the University of Manchester by Abdur Rehman Irshad 
for the degree of Doctor of Philosophy for the titled work: “Approaches 
towards a total synthesis of the phomactins” submitted in 2010. 
The synthesis of known alcohol 162 is described, the two key 
intermediates being aldehyde 160 and vinyl iodide 161. The key step of the 
synthesis of aldehyde 160 is a [2,3]-Wittig-Still rearrangement of stannane 
159 which introduces the hindered C1-C2 bond present in the phomactins. 
The vinyl iodide 161 is made in four steps from 4-pentyn-1-ol. Addition of the 
vinyl ytterbium species derived from the vinyl iodide to aldehyde 160 gave 
secondary alcohol 162. Subsequent transformations furnished the bis-
protected macrocyclic sulfone 174 in four steps from alcohol 162 to give the 
C2 SEM protected macrocycle.  
Elaboration of the macrocycle to ketoaldehyde 206 was made possible 
by the TPAP oxidation/rearrangement reaction. Reduction with DIBAL-H 
gave diol 175. Attempts at removing the sulfone appendage proved difficult 
so the diol was protected as the bis-acetate to attempt a selective epoxidation 
of the ∆3,4 olefin in the presence of the ∆1,15 olefin. Although this looked 
promising with the formation of the mono-epoxide 213, the inefficiency of 
removing the SEM group at C2 prior to the epoxidation meant the route was 
not viable. 
Removing both protecting groups from macrocycle 174 was possible 
with refluxing TBAF and after incorporating the epoxide of the ∆3,4 olefin, 
the macrocycle was elaborated to the benzyl ether 217. Applying the TPAP 
oxidation/DIBAL-H reduction sequence furnished advanced intermediate 
179 which has the full carbon skeleton found in phomactin A and also had 
oxygen functionality at all the required positions. 
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1.1 Preface. 
 
The efforts depicted within this thesis describe the pursuit towards the 
total synthesis of the marine natural product phomactin A 1, between 
September 2006 and March 2010. A macrocyclic diterpene and platelet-
activating factor antagonist, phomactin A is one member of a family of 
macrocyclic diterpenes that have enticed many among the synthetic 
community because of their biological activity and the complexity of their 
structure.  
 
 
Figure 1 
 
Of the eleven known phomactins, four have given way to total syntheses to 
date. There have been three syntheses of phomactin A and single 
syntheses of B2, D and G. Many research groups have also reported 
partial syntheses in the literature. Given the interest in the phomactins is 
primarily due to their biological activity as platelet-activating factor 
antagonists and their complex macrocyclic structures; it is prudent to 
discuss these two aspects. 
 
1.2 Platelet- activating factor 
 
Platelet-activating factor (figure 2) (1-O-alkyl-2(R)-(acetylglyceryl)-3-
phosphoryl choline) also known as PAF or PAF-acether is a low molecular 
weight chiral phospholipid that is a potent activator/mediator of many 
leukocyte functions, including platelet aggregation, inflammation and 
anaphylaxis. 
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R = C16H35 or C18H37 
Platelet Activating Factor. 
Figure 2 
 
Discovered by the French immunologist J. Benveniste in the early 
seventies, the structure was elucidated by Constantinos A. Demopoulos in 
1979.1-3 PAF is characterised by an alkyl group connected via an ether 
linkage which is generally a fully saturated sixteen or eighteen carbon 
chain-length although vinyl ether (plasmalogen) forms have also been 
detected. The acyl group at the C2 carbon which is an acetate (as opposed 
to a fatty acid), aids in the solubility of PAF and the C3 has a 
phosphocholine head group, just like standard phosphatidylcholine. 
PAF is produced by a variety of cell types including neutrophils, 
basophils, platelets, and endothelial cells in response to specific stimuli 
and has diverse physiological roles in mediating processes such as wound 
healing, apoptosis, angiogenesis, long term potentiation and reproduction. 
It causes platelets to aggregate and blood vessels to dilate; thus it is 
important to the process of hemostasis. However, PAF is also involved in 
many pathological processes as an important mediator of 
bronchoconstriction, lung inflammation, hyperresponsiveness, systemic 
anaphylaxis and systemic shock as well as gastrointestinal ulceration and 
rejection of transplant organs.4 At a concentration of 10-12 mol/L, PAF 
causes life threatening inflammation of the airways to induce asthma-like 
symptoms. These conditions are the result of excessive synthesis of PAF at 
improper locations and times which cannot be dealt with by proper 
regulation or through degradation.5 
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Although many cell types have been described as containing receptors for 
PAF, characterisation of the receptor structure at the molecular level has 
to date not been elucidated. The PAF receptor has been described as a G-
protein coupled receptor which shows structural characteristics of the 
rhodopsin (MIM 180380) gene family. An interesting observation made by 
Hwang was that the order of potency for several PAF antagonists in 
human neutrophils was different to that in human platelets, thus 
suggesting that there maybe at least two types of PAF receptor.6  
The structure of PAF suggests that a substantial degree of lipophilic 
interaction is involved in binding as the molecule contains a C16 or C18 
alkyl chain. Studies that assessed the activity of natural and synthetic 
antagonists and agonists found that reduction in the length of the alkyl 
chains or incorporation of polar groups, reduced both types of activity, 
supporting the idea of lipophilic interactions at the binding site.7, 8 Hence 
it is clear to see that PAF as a target for drug action has a high potential 
to offer new and improved treatments for various conditions. 
 
 
1.3 Discovery and isolation of the phomactins. 
 
When looking at fungal isolates from the marine environment for potential 
platelet activating factor antagonists in 1991, Sugano et al took the 
lipophilic extracts of the parasitic marine fungus Phoma Sp. found on the 
shell of a crab, Chionoecetes opilio collected from the coast of Fukui 
prefecture, Japan and screened for their ability to inhibit platelet 
aggregation by acting as PAF antagonists.9 The studies produced a novel 
PAF antagonist, phomactin A, (1) which was isolated by taking twelve 
litres of culture filtrate from the fungus, extracting with ethyl acetate and 
subjecting the organic extracts to flash and reverse phase chromatography 
to afford 3.0 mg of phomactin A. A further three phomactins were isolated 
by Chu et al in 1993, these were Sch. 49026 (4), Sch. 47918 and phomactin 
C (2).10 Four more were isolated in 1994, phomactins B (5), B1 (6), B2 (7), 
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and D (8)11 and Sugano et al published details of an additional three 
phomactins in 1995. These were phomactins E (9), F (3), and G (11).12 The 
most recent addition to the family, phomactin H (12), was reported in 2004 
and was isolated by Koyama et al from the unrelated marine fungus Isige 
okamurae, a brown alga collected at Tateishi, Kangawa Prefecture, 
Japan.13  
 
Sch. 47918,
Phomactin C 2
Phomactin E 9
Phomactin B2 7
Phomactin D 8
Phomactin B 5 Phomactin B1 6
Sch. 49026 4
Phomactin F 3
Phomactin G 11
Phomactin A 1
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The Phomactins.  
Figure 3 
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1.4 Structural features.  
 
The phomactins all contain a common carbon skeleton, a bicyclo[9.3.1] 
ring system (phomactin H has an oxepane skeleton) and can be 
distinguished from each other from the differing levels of oxygenation 
around this basic carbon skeleton. All the phomactins (with the exception 
of Sch. 49026 (4)) contain oxygen functionality at C-2 either in the form of 
a carbonyl or as the hemi-acetal tautomer as observed in phomactins A (1) 
and G (11). Phomactin A (1), arguably the most structurally complex of 
the family, has a reduced furanochroman ring as part of a tetracyclic ring 
system. Analysis of phomactin A using high resolution mass spectral 
experiments gave the molecular formula as C20H30O4, and the I.R. 
spectrum indicated the presence of a hydroxyl group (3400 cm-1). 1H and 
13C NMR spectra indicated the presence of two double bonds, one ketal, a 
secondary methyl, two tertiary methyls, and an olefinic methyl. 2-D 
Proton correlations (1H COSY) were used to further define the structure; 
however an X-ray analysis of a crystalline 4-bromobenzoyl derivative was 
required to determine the exact structure and the absolute configuration. 
 
 
Scheme 1 
Phomactins B (5) and B1 (6) have the same oxygenation and are epimeric 
only at C13. Some of the members of the phomactin family only differ 
slightly in the level of oxidation they possess. For example, phomactin C 
(2) is unsaturated between C1 and C14, whereas phomactin D (8) is a 
saturated analogue of phomactin C. Phomactin F (3) possesses an epoxy 
functionality on the ∆7,8 olefin.  
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An additional phomactin Sch49027 (Fig. 4) was reported to be have been 
isolated in 1993 by researchers at Schering-Plough that displayed levels of 
PAF inhibition comparable to phomactin A (1) and phomactin D (8).10  
 
O OH
O
OH
 
Figure 4 
 
However this was later discredited as an incorrect assignment of 
phomactin A as a result of the total synthesis of phomactin A by the group 
of Pattenden.14 The final step of this synthesis was a DDQ mediated bis-
deprotection of the epoxy-ketone 13 which resulted in spontaneous 
formation of the pyran and hemi-acetal rings to give phomactin A (1). This 
clearly demonstrated that the C14 alcohol, possessing the α 
stereochemistry, is predisposed to cyclise onto the ∆3,4 epoxide and thus 
this process would be predicted to occur in structure 13 and called into 
question the assignment of Schering-Plough researchers. 
 
 
P = PMB 
Reagents and conditions: a) DDQ, DCM/H2O ( 18 : 1 ), 0 ºC to r.t., 83%. 
Scheme 2 
 
NMR data for the synthetic phomactin A recorded in deuterated 
chloroform were identical to the NMR data reported for 13 also recorded in 
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deuterated chloroform (in the paper detailing the isolation of phomactin A, 
Sugano et al. recorded the spectrum of the natural product in deuterated 
methanol) which confirmed that the Schering-Plough researchers had 
incorrectly assigned natural phomactin A as the epoxy-acetal (Fig. 4). 
 
1.5 Biosynthesis. 
 
The hydrocarbon skeleton of Sch. 49026 (4) was proposed to be an 
intermediate in the biosynthetic pathway to the oxygenated phomactins 
by Oikawa et al.15, 16 Sch. 49026 is in turn derived from the cyclisation of 
geranyl geranyl diphosphate (GGDP) 14. An interesting point to note is 
that GGDP is known to be the starting material in the biosynthesis of the 
taxanes, a family of natural product diterpenes produced by the plants of 
the genus Taxus. The taxanes and the phomactins are derived from the 
common intermediate carbocation 16.17  
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P2O7
H
HHH
H
H
H
Taxus. Phoma.
cyclisation
1,2-H shift
1,2-Me shift
14
15
17
16
19
20
Sch. 49026. 4
18
1,2-H shift
- H+
15
10
12
1
- H+ - H+
H
 
Biosynthetic route to taxadiene and phomactatrienes. 
Scheme 3 
 
Macrocyclisation of GGDP via elimination of the phosphate gives the 
macrocycle carbocation 15 which then cyclises to give the substituted 
cyclohexane and hydride shift gives the verticillenyl carbocation 16. A 
sequence of 1,2-hydride and 1,2-methyl shifts follows to give the 
carbocation 17 in the phomactatriene pathway. A further 1,2-hydride shift  
in 17 followed by elimination of a proton gives the phomactatriene 4. An 
alternative pathway sees the loss of a proton from the carbocation 17 to 
give the phomactatriene analog 18. The pathway that leads to the taxanes 
results from an intramolecular 1,5-proton transfer in 16 followed by 
transannulation of the carbocation 19 which leads to the taxadiene 20.  
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A hypothetical biosynthetic pathway that leads to phomactin A 
incorporating some of the phomactin family as potential intermediates, 
has been suggested by Pattenden and Goldring.18 With phomactatriene 4 
as the starting point in this hypothetical pathway, selective, enzymatic 
oxidations lead to phomactin C (2). This is followed by a selective 1,4-
reduction of the enone to give phomactin D (8) which is proposed to exist 
in equilibrium with phomactin G (11). A stereoselective allylic oxidation of 
phomactin G would give allylic alcohol 21 which is predisposed to 
spontaneous pyran ring formation via the opening of the epoxide to give 
phomactin A.  
 
 
 
Hypothetical biosynthetic route to Phomactin A from Sch. 49026 (4). 
Scheme 4 
 
1.6 Structure-activity relationships (SAR). 
The results from in vitro assays of the phomactins which measured the 
inhibition of PAF induced platelet aggregation and that of PAF binding 
are given in Table 1. 
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PAF-induced 
platelet aggregation 
IC50 µM 
Inhibition of 
PAF binding 
IC50 µM 
A 10 2.3 
B 17 >47.9 
B1 9.8 20 
B2 1.6 >22.1 
Sch. 47918 (C) 6.4 63 
D 0.8 0.12 
E 2.3 5.19 
F 3.9 35.9 
G 3.2 0.38 
Sch. 49026 >36 - 
Sch. 49027 1.68 - 
 
Table 1 - Inhibition of PAF induced platelet aggregation and PAF binding 
It is clear that phomactin D was the phomactin that displayed the highest 
rates of inhibition in both assays and was thus chosen by Sugano et al as 
the lead compound in a study to probe the SAR of the structure in binding 
at the PAF receptor.19 Three segments of the molecule (Fig. 5) were probed 
by modifying/varying the functionalities. Section A looked at the effect of 
modifications at C(7-8) and sections B and C studied the functional effect 
at C20 and C2-O respectively. The analogues to probe these changes were 
synthesised by manipulation of phomactin C which were then studied for 
there binding properties by utilising assays which used rabbit platelets as 
the binding source. The ligand used to assess the modified compounds as 
PAF antagonists was [3H]PAF and the reference compound used was L-
652731 (Merck, Fig 6) which has an IC50 of 0.024 µM. 
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Figure 5 
 
  
O
MeO
MeO
MeO
OMe
OMe
OMe
L-652731  
Figure 6 
 
Table 2 shows the results from the studies where either segment A or B or 
a combination have been modified via a 1,4-reduction of the enone and 
reduction of the aldehyde in phomactin C to give the ketone and primary 
alcohol. The olefin on the ‘belt’ was either epoxidised using m-CPBA to 
give the respective epoxides or dihydroxylated using OsO4 to give the 
corresponding diols. Single diastereoisomers were observed in both 
oxidations suggesting that only the less hindered external face of the 
olefin is exposed. 
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R3 O
O
H
R1
R2  
Figure 7 
 
 
Compound R1- R2 R3 IC50 (µM) 
Phomactin 
D 
C=C CHO 0.12 
35 C=C CH2OH 1.3 
36 OH CH2OH >280 
37 −O− CHO 17.0 
38 −O− CH2OH 30.0 
 
Table 2 – SAR studies (fragment A) 
  
From the Table, it can be seen that converting the aldehyde to the alcohol 
leads to a decrease in binding activity. A much larger decrease in binding 
activity is observed when installing oxygen functionality at C(7-8), 
particularly the diol functionality indicating that hydrophobicity in this 
region is key for binding. 
Further probing of the binding properties was carried out by 
making different derivatives of fragment B where fragment C is either the 
ketone or the alcohol. Table 3 details the results where C2 is the ketone 
and segment B has been derivatized with different functionalities, 
whereas Table 4 details the results where C2 has been reduced to the β-
alcohol using NaBH4 and segment B has been derivatized with different 
functionalities as in Table 3. 
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OH
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O
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Compound R IC50 (µM) 
 
Compound R’ IC50 (µM) 
35 H 1.3  45 H 0.74 
39 
O
 
0.41  46 
O
 
0.08 
40 
O
 
1.0  47 
O
 
0.34 
41 
OPh
O
 
0.55 
 
48 
OPh
O
 
ND* 
42 
O
O
 
0.026 
 
49 
O
O
 
0.013 
43 
NMe2
O
 
0.18 
 
50 
NMe2
O
 
0.18 
44 
N O
 
0.05  51 
N O
 
0.031 
        
Table 3 – SAR studies (fragment B)  Table 4 – SAR studies (fragment B) 
 
The conclusions that can be drawn from Table 3 are that keto and 
carbamate functionality at segment B as well as the isoxazole moiety 
increase binding affinity. Table 4 shows that the β-orientated alcohol 
derivatives show an increase in binding affinity compared to the keto 
derivatives suggesting this configuration is preferable in binding to the 
receptor. Taking all these assays into consideration, the lipophilicity at 
C(7-8), the acetoxy, (methoxycarbonyl)oxy and 3-isoxazolyloxy at C-20 and 
the 2-β-OH configuration show an increase in inhibitory action compared 
to phomactin D, 8.  
As has already been mentioned previously, there have been a 
number of total syntheses of various members of the phomactin family and 
there have also been a plethora of publications regarding ongoing research 
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towards these interesting macrocyclic diterpenes. The subsequent chapter 
will discuss these various synthetic endeavours. 
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Chapter 2.  
Previous Syntheses of the Phomactins. 
 30 
2.1 Total syntheses. 
 
2.1.1 Yamada’s synthesis of phomactin D. 
 
The first total synthesis of a member of the phomactin family was that of 
phomactin D 8 by the group of Yamada published in 1996.20 The synthesis 
embarks with a double Michael addition of cyclohexenone with the chiral 
ester 23 to give the bicyclo[2.2.2.] derivative 24 setting up the important 
quaternary centre present in all the phomactins. Reduction, tosylation and 
elimination of the ketone gave the bicyclic olefin 25. Ozonolysis of the 
olefin and in situ reduction of the resulting bis-aldehyde gave the fused 
lactone 26. MOM protection of the primary alcohol and reduction of the 
lactone with LiAlH4 furnished diol 27. 
a
O
CO2Et
O
O
O
H
O
O
O
O
OH
H
CO2Et
O
O
22 24 25
CO2Et
O
O
23
O
O
HO
HO
OMOM
H
b,d
e f,g
26 27  
 
Reagents and conditions: a) LDA, THF, -78 ºC, 23, 74%; b) NaBH4, MeOH, 0 
ºC; c) TsCl, py, 0 ºC, d) DBU, PhMe, 100 ºC, 53% (3 steps); e) O3, py., DCM-
MeOH, -78 ºC, Me2S, NaBH4, 0ºC, 96%. f) MOM-Cl, i-Pr2NEt, CH2ClCH2Cl, 50ºC, 
99%; g) LiAlH4, THF, 0 ºC, 88%. 
Scheme 5 
 
Protection of the less sterically hindered alcohol as the pivalate was 
followed by TBS protection of the remaining alcohol to give 28. Reductive 
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removal of the pivalate group with DIBAL-H was followed by oxidation to 
the aldehyde. Epimerisation of the aldehyde using K2CO3 in MeOH to the 
thermodynamically more stable epimer gave a 4:1 mixture of epimers in 
favour of the more thermodynamically stable isomer. Separation of the 
diastereoisomers via column chromatography was achieved after reduction 
of to the alcohol 29.  
 
 
Reagents and conditions: a) PivCl, py., 0 ºC, 75%; b) TBS-Cl, imid, DMF, r.t., 
100%; c) DIBALH, PhMe, -78 ºC, 100%; d) PDC, 4Å MS, DCM, r.t.; e) K2CO3, 
MeOH, r.t.; f) NaBH4, MeOH, 0 ºC, 88% (3 steps). 
Scheme 6 
 
Conversion of the primary alcohol of 29 to the phenyl sulphide was 
followed by a dissolving metal reduction to install the methyl group in 30. 
Deprotection of the TBS group, transformation of the primary alcohol to 
the phenyl sulfide and subsequent oxidation gave sulfone 31. This was 
converted in three steps to benzyl ether 32. 
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Reagents and Conditions: a) PhSSPh, Bu3P, py., rt, 96%; b) Li, NH3, THF, -34 
ºC, 84%; c) TBAF, THF, rt, 100%; d) PhSSPh, Bu3P, py., N-
Phenylthiosuccinimide, 50 ºC, 100%; e) Oxone, THF-MeOH-H2O, 100%; f) AcOH, 
50 ºC; g) NaIO4, (NH4)2SO4, MeOH-H2O, 0 ºC; h) NaBH4, MeOH, 0 ºC, 97% (3 
steps); i) BnBr, NaH, THF-DMF, rt, 86%. 
Scheme 7 
 
Removal of the MOM group and oxidation gave key aldehyde 33. Addition 
of the vinyl lithium species derived from the vinyl iodide 34 furnished the 
secondary alcohol as a single diastereoisomer which was protected as its 
BOM ether 35. Deprotection of the primary allylic alcohol followed by 
formation of the allylic chloride and subsequent treatment with KHMDS 
gave the macrocycle. Global deprotection and desulfurisation preceded a 
directed stereoselective epoxidation. Finally, PDC oxidation of the primary 
and secondary hydroxyl groups resulted in the completion of the synthesis 
of phomactin D (8) 
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Reagents and conditions: a) 6M HCl, rt, 98%; b) PDC, 4Å MS, DCM, rt, 86%; c) 
t-BuLi, 68 THF, -78 ºC, 72%; d) BOM-Cl, i-Pr2NEt, 50 ºC, 94%; e) TBAF, THF, rt, 
73%; f) MsCl, DMAP, DCM, rt; g) KHMDS, THF, rt, 39%; h) Na, NH3, THF, -34 
ºC, 98%; i) VO(acac)2, t-BuOOH, C6H6, rt; j) PDC, 4Å MS, DCM, rt, 60%. 
Scheme 8 
 
The data of the synthetic phomactin D matched identically with the data 
of the natural phomactin D 
 
2.1.2 Pattenden’s synthesis of phomactin A. 
 
The group of Pattenden reported the first total synthesis of phomactin A 
in 2002 and is based upon an intramolecular Nozaki-Hiyama-Kishi 
reaction to form the macrocycle 44.14 The synthesis commences with 
alkylation of dioxin 36, first with MeI and then with the alkyl iodide 37 to 
give vinyl iodide 38. Lithiation of stannane 39 and addition into the 
ketone 38 was followed by treatment with acid to give α,β-unsaturated 
ketone 40. 
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Reagents and conditions: a) LDA, THF, -78 ºC, MeI 96%; b) LDA, DMPU, 
THF, -78 ºC, then 37, 76%; c) n-BuLi, Et2O, PhMe, -78 ºC to -25 ºC, then 2N HCl, 
THF, RT, 66%; d) p-NO2-C6H4COCl, Et3N, DMAP, DCM, -25 ºC to 0 ºC; e) 
CeCl3.7H2O, NaBH4, MeOH, DCM, -78 ºC to -40 ºC, 75% (2 steps); f) SOCl2, Et2O, 
0 ºC; g) PMBOH, t-BuOK, 18-crown-6, THF, 0 ºC, 56% (2 steps). 
Scheme 9 
 
Protection of the free alcohol of 40 as its p-nitrobenzoyl ester was followed 
by Lüche reduction of the ketone. The resulting secondary allylic alcohol 
41 was inverted by treating with thionyl chloride in Et2O at 0 ºC and then 
displacement of the resulting allylic chloride with p-methoxybenzyl alcohol 
and t-BuOK in the presence of 18 crown six to give the PMB protected 
alcohol 42. Removal of the PNB protecting group also occurred in the same 
step. 
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Reagents and conditions: a) Dess-Martin periodinane, C5H5N, DCM, 0 ºC to rt 
98%; b) CrCl2 (6eq.), NiCl2 (1eq.), DMSO, THF, rt, 36%; c) Dess-Martin 
periodinane, NaHCO3, DCM, 0 ºC to r.t. quantitative; d) CeCl3.7H2O, NaBH4, 
MeOH, DCM, -78 ºC to 0 ºC, quantitative; e) VO(acac)2, t-BuOOH, PhH, rt, 85% 
ca. 1:5 (79 and 80); Dess-Martin periodinane, C5H5N, DCM, 0 ºC to r.t., quant; g) 
DDQ, DCM/H2O (18:1), 0 ºC to r.t., 83%. 
Scheme 10  
 
The primary alcohol of 42 was oxidised using DMP and macrocyclisation 
of the resulting key intermediate 43 was carried out in the presence of 
CrCl2/NiCl2 to give macrocycle 44 in an unoptimised yield of 36%. The 
secondary alcohol of 44 was inverted via an oxidation/reduction sequence 
and subsequent epoxidation using VO(acac)2 and t-BuOOH resulted in a 
1:1 mixture of the bis-epoxide 46 and the required β-mono-epoxide 45, 
which were separable by chromatography. Oxidation of the secondary 
alcohol to give epoxy ketone 13 was followed by bis-PMB deprotection 
which led to the spontaneous pyran-hemiacetal formation leading to (±)-
phomactin A. 
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2.1.3 Halcomb’s synthesis of phomactin A. 
 
The first non-racemic synthesis of phomactin A was published in 2003 by 
the group of Halcomb and incorporated a B-alkyl Suzuki coupling reaction 
to form the macrocycle.21  
 
O
I
OH
OP
B-alkyl Suzuki
coupling
O
Epoxide
opening
Deprotection
O
O OH
OH
47 1  
Synthetic strategy for phomactin A. 
Scheme 11 
Using commercially available (R)-(+)-pulegone to introduce the chirality at 
the onset of the synthesis, (R)-(+)-pulegone was converted to 2,3-
dimethylcyclohexanone by methylation and a retro aldol reaction. This 
was taken through to enone 48 via a bromination/elimination sequence. 
An aldol condensation with phenylselenoacetaldehyde installed the 
quaternary stereocentre and the resulting β-hydroxy ketone gave vinyl 
substituted enone 49 upon treatment with MsCl and triethylamine with 
complete diasteroselectivity. This was transformed to enone 50 via tin-
lithium exchange with [(methoxymethoxy)-methyl]tributylstannane 
followed by 1,2 addition of the resulting anion to enone 49. Treatment 
with PCC furnished enone 50 via an oxidative rearrangement.  
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Reagents and conditions: a) LDA, Li, MeLi, 70%; b) KOH, reflux, 75%; c) LDA, 
TMS-Cl, Br2, 90%; d) Li2CO3, LiBr, DMF, 81%; e) LDA, 
phenylselenoacetaldehyde, 73%; f) MsCl, Et3N, 86%; g) n-BuLi, 
Bu3SnCH2OMOM, LiCl, 70%; h) PCC, 91%; i) NaBH4, CeCl3; j) m-CPBA, 81% for 
two steps; k) Dess-Martin periodinane, 86%; l) MgBr2·Et2O, 83%; m) TFAA, Pyr., 
95%; n) MgBr2·Et2O, BuSH, 91%; o) CSA, DMB-ONPyr, 85%; p) NaBH4, CeCl3, 
94%; q) PPh3, DEAD, p-nitrobenzoic acid, then NaOCH3, 86%; r) TBS-Cl 92%. 
Scheme 12   
Steroselective Lüche reduction of enone 50 followed by epoxidation with 
m-CPBA gave epoxy alcohol 51. Dess-Martin oxidation of the alcohol and 
regioselective opening of the epoxide gave the bromohydrin 52. The vinyl 
bromide was formed via acetylation of the tertiary alcohol with TFAA 
followed by elimination. Stereoselective Lüche reduction and TBS 
protection to give the secondary TBS ether was carried out after having 
changed the protecting group on the primary alcohol from a MOM group to 
a DMB group to give 54. 
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Reagents and conditions: a) CBr4, PPh3, Zn; b) n-BuLi, Et2O, 0 ºC, 92% for two 
steps; c) n-BuLi, MeLi, THF, -78 ºC, 88%; d) TBAF, THF; e) TBS-Cl, 94% for two 
steps; f) Cp2ZrHCl, 40 ºC, 12 hours; then I2, 0 ºC, 65%; g) TBAF, THF, 92%; h) 
TBHP, (-)-DIPT, Ti(O-iPr)4, sieves; i) Py.·SO3, DMSO, Et3N, 66% for two steps. 
Scheme 13. 
The side chain for the macrocycle was synthesised from known aldehyde 
55.22 A Corey-Fuchs reaction was utilised to convert the aldehyde to a 
terminal alkyne which was then methylated to give 56. A change of 
protecting group, conversion of the alkyne to the vinyl iodide 57 by a 
hydrozirconation/iodination procedure and TBAF deprotection gave the 
primary alcohol. Epoxidation using Sharpless conditions followed by 
oxidation of the primary alcohol gave the epoxy aldehyde 58. 
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Reagents and conditions: a) t-BuLi, -78 ºC, then 58; b) Dess-Martin 
periodinane, 45% for two steps; c) TBAF, THF, 91%; d) 1% HCl, tert-amyl alcohol, 
65%; e) TES-Cl, 83%; f) DDQ, 87%; g) TMS-OTf, Pyr. 0 ºC, 81%; h) 9-BBN, THF, 
40 ºC; then H2O; Pd(dppf)Cl2, AsPh3, Tl2CO3, 6:3:1 THF:DMF:H2O, rt, 37%; i) 
TBAF, THF, 78%. 
Scheme 14 
Lithiation of bromide 54 and addition to aldehyde 58 followed by oxidation 
of the resulting allylic alcohol gave ketone 59. TBS deprotection was 
followed by formation of the pyran ring in 60 upon treatment with acid. 
The resulting secondary alcohol was protected as a TES ether before 
removal of the DMP group and spontaneous cyclisation to form the 
hemiacetal which was protected as its TMS ether 61. The vinyl 
substituent was then hydroborated with 9-BBN to give an intermediate 
alkyl borane, to this was applied a modification of Johnsons conditions in 
the Suzuki coupling to form the macrocycle. Bis-deprotection using TBAF 
then completed the synthesis of phomactin A. 
 
2.1.4 Pattenden’s synthesis of phomactin G. 
 
Having already synthesised phomactin A, the group of Pattenden 
published a total synthesis of phomactin G (11) in 2004.23 The Cr(II)/Ni(II) 
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mediated macrocyclisation was again the key step, the precursor for this 
reaction was made in 3 steps from 41 from the original synthesis of 
phomactin A. 
 
 
 
Reagents and conditions: a) MsCl, DIPEA, DCM, 0 ºC to r.t., 99%; b) LiBH4, 
THF, 86%; c) Dess-Martin periodinane, NaHCO3, DCM, 0 ºC to rt, 99%; d) CrCl2 
(6 eq.), NiCl2 (1 eq.), DMSO, THF, rt, 47%; e) Dess-Martin periodinane, NaHCO3, 
0 ºC to r.t., 99%; f) CeCl3.7H2O, NaBH4, MeOH, DCM, -78 ºC to 0 ºC, 81%. 
Scheme 15 
 
Deoxygenation of the secondary alcohol was carried out via mesylation 
followed by treatment with LiBH4 to give the reduced cyclohexene ring 
and removal of the PNB group gave alcohol 62. This was oxidised to the 
aldehyde vinyl iodide 63 and then treated with CrCl2 and NiCl2 to furnish 
macrocycle 64. Inversion of the doubly allylic alcohol was carried out via 
an oxidative/reductive sequence to give 65. 
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Reagents and conditions: a) Dimethyl dioxirane (0.5eq.) acetone-water (1:1), 0 
ºC to rt, 31%; b) Dess-Martin periodinane, NaHCO3, 0 °C to r.t., 99%; c) DDQ, 
DCM-H2O (18 : 1), 0 °C to rt, 73%. 
Scheme 16 
The use of 0.5 equiv dimethyldioxirane resulted in the formation of the 
mono-epoxide 66 exclusively in 31% yield. Oxidation of the epoxy alcohol 
with DMP followed by a DDQ mediated deprotection gave (±) phomactin G 
(11). 
 
 
2.1.5 Wulff’s synthesis of phomactin B2. 
 
In 2007, the group of Wulff published the first total synthesis of 
phomactin B2.24 An interesting distinction between the approach of Wulff 
and previous synthetic efforts towards the phomactins was to assemble 
the functionalised 6 membered ring and the 12 membered macrocycle 
simultaneously, whereas previous syntheses had focused on forming the 
functionalised 6 membered ring before the macrocycle. Wulff et al. were 
able to achieve this via an intramolecular cyclohexadienone annulation of 
a chromium carbene complex. 
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Reagents and conditions: a) LiCH2C≡CTMS; b) TBAF; c) ZrCp2Cl2, AlMe3 then 
I2; d) DMP; e) BrMgC≡CH; f) TIPSCl, DMAP; g) i. Cr(CO)6, THF, -78 ºC; ii. PhLi, 
-78 ºC; iii. n-BuLi; iv. Me3OBF4, 25 ºC, DCM/H2O. 
Scheme 17 
 
The annulation precursor 73 was synthesized in seven steps from known bromide 
68.25 1-Trimethylsilyl propargyl lithium was used to displace the bromide 
and deprotection gave allylic alcohol 69. A Negishi 
carboalumination/iodination installed the E-vinyl iodide which was 
followed by oxidation with DMP. 1,2 Addition of ethynyl Grignard gave 
propargyl alcohol 71 which was protected as its TIPS ether. The Fisher 
method was then utilised to prepare the carbene complex.26 Phenyllithium 
was used to deprotonate the alkyne the presence of the chromium carbonyl 
before addition of n-BuLi to generate the dianion. This was quenched by 
the addition of Me3OBF4 to give 73. 
 A 4:1 mixture of separable diastereoisomers was obtained from the 
intramolecular cyclohexadione annulation of the complex 73 with the 
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major diastereomer 74 having the correct stereochemistry for the 
synthesis. 
 
 
Reagents and conditions: a) THF, 60 ºC, 40 hours, 66%; b) TBAF, 83%; c) 
MOMCl,  i-Pr2EtN, 88%; 
Scheme 18 
 
Having replaced the TIPS protecting group for a MOM group, the ketone 
was converted to the exocyclic olefin via a Peterson reaction sequence to 
give the enone 76 after hydrolysis of the enol ether. Methylation alpha to 
the ketone was achieved stereoselectively before switching of the MOM 
protecting group to the TIPS group. NaBH4 reduction of the ketone gave 
an inseparable mixture of diastereoisomers 77. These were converted to 
their acetates in an effort to suppress a competing epoxidation reaction of 
the wrong allylic alcohol in future steps before TBAF deprotection of the 
TIPS group allowed for separation of the diastereisomers 78 and 79 
respectively. 
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Reagents and conditions: a) LiCH2SiMe3; b) KHMDS; c) HCl/MeOH; d) 
LiHMDS, MeI; e) MeOH/HCl; f) TIPSCl, DMAP; g)NaBH4; h) Ac2O, pyr.; i) TBAF. 
Scheme 19 
 
After epoxidation of both acetates, epoxy-alcohol 80 was oxidised to the 
ketone and hydrolysed to give phomactin B2. The same transformations 
were applied to the epoxy-alcohol 81 which yielded phomactin B2 after 
Mitsunobu inversion of the allylic alcohol 82. 
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Reagents and conditions: a) VO (acac)2, t-BuOOH; b) DMP; c) aq. NaOH, 
MeOH; d) PNBA, DEAD, PPh3, K2CO3, MeOH. 
Scheme 20 
 
This methodology has the potential to tackle many of the phomactins as it 
provides a quick entry into the common core of the phomactin family via 
the intermediate 74a which has functionality to elaborate upon towards 
various members of the phomactin family.  
 
2.1.6 Hsung’s synthesis of phomactin A 
 
The most recent synthesis of phomactin A is that of Hsung et al. based on 
a formal intermolecular oxa-[3+3] approach for the construction of 1-
oxadecalins by the reaction of 1,3-diketones with α,β-unsaturated iminium 
salts.27-29 These reactions proceed via a Knoevenagel condensation 
followed by a 6π-electron electrocyclic ring closure, and after encouraging 
results for intramolecular reactions on model systems, they applied this 
methodology to tackle the tricyclic intermediate 83.30  
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Scheme 21 
 
The synthesis towards the phomactin type iminium precursor started with 
1,4-addition of a dimethyl cuprate to enone 85, from which  the resulting 
enolate was trapped out as the α-allyl ketone 86 by electrophilic quench 
with allylbromide. Reduction of the ketone and protection of the resulting 
secondary alcohol as its PMB ether was followed by hydroboration and 
Swern oxidation to give the aldehyde 87. Homologation and installation of 
a terminal alkyne was carried out according to the Corey-Fuchs procedure 
to give 88 which was converted to the vinyl iodide 89 by a 
hydrozirconation/iodination reaction. 
 
 
 
 
 
Reagents and conditions: a) Me2CuLi, Et2O, then allylBr, DME, 0 ºC, 72%; b) 
LiAlH4, Et2O, -78 ºC; c) NaH, DMF, PMB-Cl; d) BH3/Me2S then NaOH/H2O2; e) 
DMSO, Et3N, (COCl)2, 42% (4 steps); f) CBr4, PPh3; g) n-BuLi, -78 ºC, 79% (2 
steps); h) Cp2ZrCl2, AlMe3, r.t. then I2, THF, -45 ºC, 68%. 
Scheme 22 
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Elongation the side chain of 89 was achieved using a B-alkyl Suzuki 
coupling. The boron coupling partner for this reaction was efficiently 
assembled from TBDPS protected prenyl alcohol 90 following a double 
oxidation/homologation sequence to give the diene 91. Hydroboration 
followed by a palladium-catalysed coupling reaction gave diene 92.   
 
 
 
Reagents and conditions: a) SeO2, TBHP then NaBH4; b) MnO2; c) Ph3PCH2, 
56% (3 steps); d) Cy2BH, THF; e) 89, 8% PdCl2(PPh3)2, aq. K3PO4, DMF, 94%. 
Scheme 23 
 
With the side chain complete, the focus of the synthesis was switched to 
the incorporation of the 1,3-diketone motif into the functionalised six 
membered ring. DDQ deprotection of the PMB group followed by an 
oxidation with TPAP and NMO to give an intermediate ketone that was 
converted to the α,β-unsaturated ketone 93. This was then subjected to a 
nucleophilic epoxidation reaction to give the α-epoxide 94 as the only 
observed diastereoisomer. SmI2 reduction at low temperature opened the 
epoxide in a completely regioselective manner and the resulting β-hydroxy 
ketone was oxidised to the to the 1,3-diketone 95 using PCC. 
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R = side chain 
Reagents and conditions: a) DDQ, H2O; b) TPAP, NMO; c) LDA, PhSeBr then 
H2O2/THF, 27% (3 steps); d) K2CO3, H2O2, MeOH, 94%; e) SmI2; f) PCC, 64% 
(2steps). 
Scheme 24 
 
Due to the sensitivity of the 1,3-diketone, it was protected as its 
vinylogous methyl ester 96. The two possible regioisomers from this 
reaction were observed in a 1:1 ratio and easily separated, thus undesired 
isomer was hydrolysed and put back through the esterification reaction to 
avoid a significant loss of material. TBAF deprotection and subsequent 
oxidation of the revealed allylic alcohol gave the α,β-unsaturated aldehyde 
moiety of the side chain. Hydrolysis of the methyl ester reinstalled the 1,3-
diketone to give the precursor to the oxa-[3+3] cycloaddition 98.  
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Reagents and conditions: a) K2CO3, MeSO4, acetone, rt, 96%; b) KOH, THF, 
MeOH, H2O, 78%; c) TBAF, THF; d) Dess-Martin; e) 3N HCl, 88% (3 steps). 
Scheme 25 
 
Using conditions of high dilution (5 mL/mg), the reaction proceeded to give 
3 intramolecular cycloaddition products. 
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Reagents and conditions: a) Piperidinium acetate, THF, rt, 76%. 
Scheme 26 
 
The desired 12-membered macrocycle product 99 turned out to be the 
minor product while the major products were a 4:1 inseparable mixture of 
atropisomers 100 and 101. Product ratios were 2.2:[4:1] = 99:[100:101]. 
Fortunately, the undesired tricycles 100 and 101 could be equilibrated 
efficiently under the same reaction conditions to give 99 while establishing 
a ratio of 1.7:[4:1] for 99:[100:101]. The addition of excess acetic anhydride 
led to a more efficient equilibration. Scheme 26 shows the process the 
equilibration is believed to proceed through. 
 
Scheme 27 
 
With the ability to synthesise sufficient quantities of tricycle-ABD 99, 
attention was turned to oxidising the C3-3a olefin. This was achieved via a 
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singlet-oxygen Diels-Alder cycloaddition. The resulting endoperoxide was 
cleaved using potassium acetate and 18-crown-6 to give ene-dione 106. 
This was subsequently converted to methyl ether 107 by treating with 
acidic methanol. Selective reduction of the C-3 carbonyl was achieved by 
use of L-selectride™. 
 
 
Reagents and conditions: a) Air and Rose Bengal, DCM, -78 °C, hν: 300W 
lamp, 65%; b) KOAc, 18-c-6, THF, rt, 94%; c) pTsOH, MeOH, rt, 81%; d) L-
Selectride™, THF, -78 °C, H2O2, 91%. 
Scheme 28 
 
TES protection of the alcohol 108 followed by de-methylation of the C3a 
alcohol gave secondary alcohol 109. The C3a-OH had to be oxidised so that 
1, 4-reduction could be achieved of the ring junction C8a. Reduction 
initially gave diketone 110, which was isolable, but with extended 
reduction time at temperatures slightly higher than rt, hydroxy-ketone 
111 was obtained in 96% overall yield. 
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Reagents and conditions: a) TES-Cl, imid, DCM, rt; b) BBr3 (3 eq), -78 °C, 2-
methyl-2-butene, 68% (2 steps); c) Dess-Martin [O]; d) NaBH4, MeOH, 96% (2 
steps). 
Scheme 29 
 
During an attempt to chlorinate at C3a, sulfite 112 was isolated. 
Extrusion of SO2 in refluxing toluene gave enone 113. This was 
subsequently converted to epoxy ketone 114 in three steps. Homologation 
of the C5a position was then achieved via addition of MeLi followed by 
elimination to give vinyl epoxide 115. 
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Reagents and conditions: a) SOCl2, anhyd pyr, 0 °C, 85%; b) Toluene, reflux, 
95%; c) p-TsOH, MeOH, 50 °C; d) K2CO3, H2O2, MeOH, rt; e) TES-Cl, imid, DCM 
89% (3 steps); f) MeLi (excess), Et2O, 0 °C; g) SOCl2, anhyd pyr, 0 °C, 54% (2 
steps). 
Scheme 30 
 
Opening of the epoxide with Mg(OTf)2 in wet acetonitrile, resilylation of 
the C3-OH followed by conversion to epoxy-diol 117 was achieved by using 
PCC on basic alumina. Treatment of 117 with Ph3P-I2 gave enal 118. 
Luche reduction, acetylation of the primary allylic alcohol was followed by 
a Dess-Martin oxidation and a deprotection sequence to complete the total 
synthesis of (±)-phomactin A. 
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Reagents and conditions: a) Mg(OTf)2, CH3CN/EtOAc/H2O; b) TES-OTf, 2, 6-
lutidine, 50% (2 steps); c) PCC on basic alumina, 55%; d) Ph3P, I2, DCM, rt; e) 
NaBH4, CeCl3, MeOH, 50% (2 steps); f) Ac2O, pyridine, rt; g) Dess-Martin [O], 50 
°C; h) TBAF, THF; i) K2CO3, MeOH, 50% (4 steps). 
Scheme 31 
 
2.2 Partial syntheses. 
 
Many other groups have reported varying strategies toward the 
phomactins which have not yet been realised. The group of Danishefsky 
has approached the phomactin core via a Diels-Alder approach.31 
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Scheme 32 
 
The Diels-Alder reaction of 120 with maleic anhydride gave cyclo-adduct 
122 as the only stereoisomer although the product is the epimer at the 
C14 proton. Other research groups to have published their approaches 
include the groups of Totah, Maleczka, Rawal and Cho.32-36 
 
 
2.3 Previous work from the Manchester laboratories. 
 
The E. J. Thomas group approach to the phomactins has been based 
around the [2,3]-Wittig rearrangement of cyclohexyl-allylic ethers. These 
efforts have been outlined below. 
The [2,3]-Wittig rearrangement allows the synthesis of homoallylic 
alcohols by the base-induced rearrangement of allyl ethers at low 
temperatures. 
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HO
R
 
Figure 8 
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The reaction is a [2,3]-sigmatropic thermal isomerization that proceeds 
through a six-electron, five-membered cyclic transition state. The base 
used to initiate the reaction is typically an alkyl lithium at low 
temperature to avoid competing [1,2] rearrangement and where R is a 
carbanion stabilising group such as an alkene or alkyne. The driving force 
for the reaction is typically the formation of a more stable anion. 
 
2.3.1 1993-1996. 
 
A. K. Marsden looked into the [2,3]-Wittig rearrangement of cyclohexyl-
allylic ether model 123 to establish the quaternary centre at the C-1 to C-2 
bond as found in phomactin A.37  
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 Reagents and conditions: a) n-BuLi, THF, 75%; b) Oxalyl chloride, DMSO, 
DCM, -78 ºC, Et3N, 82%; c) Me2CuLi, THF, 77%; d) PPTS, EtOH, H2O, 40%. 
Scheme 33 
 
A mixture of diastereoisomeric propargylic alcohols was obtained in 75% 
yield when ether 122 was treated with n-BuLi at -78 ºC. Oxidation of 123 
followed by addition of dimethylcuprate gave the enone 125 as a mixture 
of separable diastereoisomers. Ketal deprotection and isomerisation of the 
∆15,20 occurred upon treatment with PPTS in ethanol to give the 
conjugated ∆1,15 alkene 126. 
 56 
Elaboration of the side chain prior to etherification allowed for 
investigation into the effect of a more complex alkyne moiety on the [2,3]-
rearrangement and introduced a degree of convergence into the synthesis.  
 
2.3.2 1996-1999. 
 
A more functionalised cyclohexene core was synthesised by P.D.P 
Shapland using a Birch reduction pathway.38  Birch reduction of ortho-
toluic acid and subsequent transformations resulted in the acetal 
protected allylic bromide 129. 
 
HO
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O
O
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O
O
Br
a-c d-f
127 128 129  
 
Reagents and conditions: a) Li, liq. NH3, THF, -78 ºC, MeI, 99%; b) AcCl, 
MeOH, 91%; c) PDC, TBHP, celite, C6H6, 69%; d) Me2CuLi, Et2O, 89%; e) NBS, 
AIBN, CCl4, reflux, 67%; f) 1,2-Ethanediol, PPTS, C6H6, Dean-Stark, 95%. 
Scheme 34 
 
Williamson etherification with side chain moiety 130 followed by 
reduction of the ester and protection of the alcohol as its TBS ether gave 
131. On application of the [2,3]-Wittig rearrangement, a mixture of two 
diastereoisomers was obtained as shown.  
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R = (CH2)3OTBDPS 
 
Reagents and conditions: a). NaH, THF, reflux, 50%; b). Super-Hydride, 
THF, 0ºC, 91%; c). TBS-Cl, imidazole, DCM, 80%; d). n-BuLi, THF, -78 ºC, 79%, 
5:2 (226α:226β). 
Scheme 35 
 
To further investigate the influence of stereochemistry at this point, the C-
14 carbonyl protecting group was converted to a secondary protected TIPS 
ether in three steps from 131 to give 133.  
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d
133
134α 134β 134δ
R = (CH2)3OTBDPS 
Reagents and conditions: a) PPTS, acetone, H2O, 92%; b) NaBH4, 
CeCl3.H2O, methanol, 98%; c) TIPSCl, imidazole, DMAP, DCM, 99%; d). n-
BuLi, THF, -78 ºC. 
Scheme 36 
 
Application of the [2,3]-Wittig rearrangement by treatment of 133 with n-
BuLi resulted in the formation of a mixture of the three isomeric alcohols 
(Scheme 36). Upon oxidation, alcohols 134α and 134β gave the same 
alkynone 135. When treated with dimethylcuprate, unfortunately an 
inseparable 1:1 mixture of the E and Z  enones was obtained. 
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H
O
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H
O
R
R
136E 136Z
a b
 
R = (CH2)3OTBDPS 
Reagents and conditions: a) TPAP, NMO, 4Ǻ MS, DCM, 77%; b) Me2CuLi, 
Et2O, 0ºC. 
Scheme 37 
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Investigations to introduce the C-20 oxygen and isomerisation of the 
exocyclic ∆15,20 alkene to the ∆1,15 internal alkene were also carried out. β,γ-
Epoxy ketone 137, derived from epoxidation of the exocyclic alkene in 135, 
was subjected to both basic and acidic conditions independently.  However, 
rearrangement proved unsuccessful under both conditions. Under basic 
conditions decomposition was observed and under acid conditions 
dehydration followed the desired isomerization to give the undesired fused 
furan 138. 
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R = (CH2)3OTBDPS 
 
Reagents and conditions: a) m-CPBA, NaHCO3, DCM, 73%. 
Scheme 38 
 
 
2.3.3 1999-2002. 
 
G. McGowan further elaborated on the Birch reduction pathway originally 
developed by Shapland.39 A full side chain moiety was installed and the 
ester moiety converted to a sulfone appendage 140 that would be 
necessary for the proposed macrocyclisation.40 With these modifications in 
place, 140 was further elaborated to evaluate the macrocyclisation. 
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d
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P = SEM 
Reagents and conditions: a) TIPS-OTf, 2,6- lutidine, DCM, 0 ºC, 87%; b) 5% 
NaOH, i-PrOH, 54%; c) MsCl, Et3N, LiBr, DCM, acetone, 0 ºC, 86%; d) NaHMDS 
(syringe pump), 0 °C, THF, 31 %. 
Scheme 39 
 
After having protected the secondary alcohol of 140 as its TIPS ether, the 
primary allylic alcohol was deprotected and converted to the allylic 
bromide 142 via mesylation and displacement with LiBr. Slow addition of 
NaHMDS to the allylic bromide proceeded to give the cyclised product in a 
modest 31% yield. TIPS deprotection and followed by reductive 
desulfonylation gave macrocyclic carbinol 145. At this point there 
remained the installation of the C-16 methyl group to complete the carbon 
skeleton of phomactin.  
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P = SEM 
 Reagents and conditions: a) TBAF, THF, r.t.; b) Na/Hg, Na2HPO4, MeOH, 0 
ºC. (60% over the two steps) 
Scheme 40 
 
Attempts to iodinate carbinol 145 using Red-Al® or a combination of 
LiAlH4 and NaOMe followed by quenching with iodine according to the 
procedure of Corey et al returned starting material. 
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Scheme 41 
 
An alternative approach looked at incorporation of the C-16 methyl via 
1,4-addition reactions of alkynone 147. Following a procedure described by 
Mukaiyama et al.41 alkynone 147 was treated with thiophenol and base to 
give a mixture of enones that was significantly enriched in the Z-trans-
isomer 149. 
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Reagents and conditions: a) PhSH, Et3N, THF, MeOH,-20 ºC, 26% (of 244) and 
69% (of 245). 
Scheme 42 
 
When treated with dimethylcuprate, an addition elimination reaction 
ensued with complete retention of configuration to the give the E-enone in 
97% yield from the Z-vinyl sulfide 149. 
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 Reagents and conditions: a) MeLi, CuI, Et2O, 0 ºC -78 ºC, add 245, -78 ºC, 
97%. 
Scheme 43 
 
Attempts to protect the ketone in 150 as the acetal, using ethylene glycol 
before taking it through to the macrocycle proved unsuccessful. 
Alternative strategies included a reduction then protection sequence. After 
screening many reducing agents, NaBH4 in ethanol provided useful levels 
of 1,2- vs 1,4-reduction (although not always consistent), giving a 57% 
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yield of one diastereoisomer 151 as well as the 1,4 reduction  product 153 
and totally reduced product 152.  
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 Reagents and conditions: a) NaBH4, EtOH, r.t. 57% (of 248) 
Scheme 44 
 
The secondary alcohol 151 was then protected as the BOM ether and 
taken through to the carbinol macrocycle 156 according to the previously 
developed route. 
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P = SEM 
 
Reagents and conditions: a)BOM-Cl, i-Pr2NEt, TBAI, THF, r.t. 85%; b) TBAF, 
THF,r.t. 79%; c) MsCl, Et3N, LiBr, DCM, acetone, 0 ºC, 69%; d)NaHMDS, THF, 0 
ºC; e) Na, liq. NH3, THF, EtOH, -60 ºC, 45% (from 154) 
Scheme 45 
 
Although progress had been made to the methylated carbinol 156 the 
reduction of the ketone 150 proved too inefficient to maintain adequate 
supplies of frontline material to further the synthesis.  
 
 
2.3.4 2002 – 2006 
 
OSEM
PhSO2
O
OTBDPS
Hα
α'
157
H
 
Figure 9 
 
M. J. Kilner attempted to overcome the problematic alkyne reduction by 
installing the E olefin at an earlier point of the synthesis to give the [2,3]-
 65 
Wittig precursor of the type 157.42 However, attempted [2,3]-Wittig 
rearrangements met with failure leading to a reassessment of the 
strategy. 
Another variant of [2,3]-Wittig rearrangement was the extreme case 
reported by Still in 1978 in which the unstable oxy-methyllithium is 
generated by tin-lithium exchange and the resulting rearrangement gives 
primary homoallylic alcohols which are usually (Z)-selective (Scheme 
46).43  
 
OH O SnBu3
OH
a b
A A' B
 
a) KH, THF, -78 ºC; Bu3SnCH2I; b) n-BuLi, THF, -78 ºC. 
 
Scheme 46 
 
Trialkyltin ether 158 was found to provide a good alternative entry to the 
Wittig reaction via the Wittig-Still variant.44 Tin/lithium exhange followed 
by the rearrangement gave the primary alcohol 158 which was then 
oxidised to aldehyde 160. 
 
 
Reagents and conditions: a) n-BuLi, THF, -78 ºC, 60%; b) i-Pr2NEt, Pyr.SO3, 
DMSO, DCM, 0 ºC, 90%.  
Scheme 47 
Addition of a vinyl lithium species derived from 161 to the aldehyde in a 
modest 43% yield followed by subsequent side chain manipulations and 
macrocylisation via the sulfone gave the macrocycle 163.  
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P = TBDPS 
  
Reagents and conditions: a) t-BuLi, THF, -78 ºC, 43%; b) i-Pr2NEt, BOMCl, 
TBAI, THF, rt, 76%; c) AcOH: THF: H2O, 3:1:1, rt; d) MsCl, Et3N, LiBr, THF, 
0ºC, 66%; e) NaHMDS, THF, 0 ºC, 71%. 
Scheme 48 
 
2.3.5 2006 – 2008 
 
More recent work from these laboratories has focused on optimising the 
side chain 161 addition to the aldehyde 160 core and functionalising the 
macrocycle further. 
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iii
 
 Reactants and Reagents: a) i. t-BuLi ii. Yb(OTf)3 iii. 160, THF, -78 ºC, 85%. 
Scheme 49 
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The use of organolithium reagents that had been used previously by M. J. 
Kilner gave the adduct 162 in a modest 43% yield along with unwanted 
based-induced elimination products of the starting aldehyde. T. J. 
Blackburn investigated the use of different organometallics for the side 
chain addition and found that organoytterbium reagents gave the best 
results.44 
Transmetallation of the vinyl lithium species formed from the 
addition of t-BuLi to the side chain 161 with Yb(OTf)3 followed by addition 
to the aldehyde 160 gave the adduct  162 in a much improved 85% yield. 
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Reactants and Reagents: a) TBAF, THF, rt. 95%; b) NH3, Na, EtOH, THF,           
-78 ºC, 86%. 
Scheme 50 
 
Having taken the adduct 162 through to the macrocycle according to the 
previously developed procedure, removal of the protecting groups and the 
sulfone gave diol 165. 
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Reagents and conditions: a) VO(acac)2; TBHP, C6H6, rt, 85%. 
Scheme 51 
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Epoxidation of the diol 165 gave in good yield mono-epoxy diol 166. 
However, all attempts to epoxidise the terminal olefin met with failure. 
When attempting to oxidise the alcohol at the C-14 position in 164, 
the use of TPAP/NMO surprisingly gave the ene-ketoaldehyde 168 with 
the olefin having migrated to the internal position as found in phomactin 
A. Stereoselective reduction of the keto-aldehyde was achieved with 
DIBAL-H.44 
 
 
Reagents and conditions: a) TPAP, NMO, 4 Å MS, DCM, r.t. 78%; b) DIBAL-
H, DCM, -78 ºC, 66%. 
Scheme 52 
 
However, the formation of the ∆1,15 olefin at this stage presented a 
problem that had been encountered by Pattenden et al. in their total 
synthesis of phomactin A as shown in scheme 53.  
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P = PMB 
Reagents and conditions: a) VO(acac)2, t-BuOOH, PhH, r.t., 85% ca. 1:1 (79 
and 80). 
Scheme 53 
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Treatment of the bis-protected diol 44 with VO(acac)2 and TBHP resulted 
in the desired epoxide 45 but in a 1:1 ratio with the bis-epoxide 46. The 
ene-ketoaldehyde 168 presented the same problem as the ∆1,15 olefin had 
been installed before epoxidation of the ∆3,4 epoxide and so would mean 
that the C2 directed epoxidation would occur on a bis-allylic alcohol. 
Dr Alan Lee attempted to circumvent this problem by applying the 
TPAP oxidation on a system which had already incorporated the ∆3,4 
epoxide. Regioselective silylation of the dihydroxyepoxide 166 with TBSCl 
was followed by alkylation of the free hydroxyl at C2 to give benzyl ether 
171. 
 
 
Reagents and conditions: a) TBSCl, imid., r.t. 16h, 99%; b) KHMDS, BnBr, 
TBAI, THF, -78 ºC to rt, 16h, 99%; c) TBAF, THF, r.t., 16h, 99%. 
Scheme 54 
 
Removal of the TBS group with TBAF was followed by oxidation with 
TPAP which proceeded as expected to give the epoxyketo-aldehyde 172. 
Reduction with DIBAL-H gave mainly diol 173 which was shown to have 
the wrong configuration at C14 by determination of the X-ray crystal 
structure of its diacetate. 
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Reagents and conditions: a) TPAP, NMO, 4 Å MS, DCM, r.t., 1h 62%; b) 
DIBAL-H, DCM, -78 ºC, 1h, 69% (plus 11% epimer at C14). 
Scheme 55 
 
The reductions of keto-aldehydes 168 and 172 using DIBAL-H 
unexpectedly gave opposite stereoselectivities with respect to the ketone 
functionality at C14. This may be due to the phenylsulfonyl group in keto-
aldehyde 168 shielding the lower face of the ketone causing hydride attack 
which leads to the required configuration at C14 in alcohol 169. 
 
2.4 Proposed strategy for the synthesis of phomactin A. 
 
Taking into account the opposite stereochemistry observed from the 
reduction of the two keto-aldehydes 168 and 172, it would be prudent to 
keep the phenylsulfone in place and remove it after the reduction of the 
keto-aldehyde moiety. 
Two potential routes which are shown below that would require a 
changing of the protecting group used at C2 to be orthogonal to the 
conditions which remove the sulfone seem plausible. 
 
 71 
174
OSEM
PhO2S
OP
OSEM
PhO2S
175
HO
OH
176
OH
AcO
OAc
177
O
AcO
OAc
O phomactin A
 
Scheme 56 
 
The first route (scheme 56) envisages the alternative macrocycle 174 (with 
a SEM or TIPS protecting group at C2 as opposed to the BOM group), 
being taken through to the diol via selective removal of the C14 silyl 
group, TPAP oxidation to give the expected keto-aldehyde which would 
then be reduced with DIBAL-H giving what would be the expected 
stereochemistry at C14 (175) as found in phomactin A as the 
phenylsulfone appendage is still present. 
At this point the phenylsulfone could be removed via a dissolving 
metal reduction and the two free alcohols at C14 and C20 protected as 
their acetates before unmasking the the C2 alcohol. The objective of the 
acetates would be to deactivate the ∆1,15 olefin compared to the ∆3,4 olefin 
in the hope to avoid competeing epoxidation at the wrong position. 
Directed epoxidation of the ∆3,4 olefin followed by oxidation of the 
C2 alcohol would give keto-epoxide 177. Removal of the acetates and 
subsequent formation of the pyran and hemiacetal rings is expected to 
give phomactin A. 
An alternative strategy which would see the incorporation of the 
∆3,4 epoxide before the TPAP oxidation/reduction sequence is outlined 
below. 
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Scheme 57 
 
Removal of the C2 protecting group followed by epoxidation of the ∆3,4 
olefin and alkylation of the C2 alcohol would give benzyl ether 178. 
Desilylation at C14 followed by the TPAP oxidation/reduction sequence 
would give the expected epoxy-diol 179. Protection of the two free alcohols 
at C14 and C20 with a suitable silyl protecting group would be followed by 
removal of the phenylsulfone and the benzyl group via a dissolving metal 
reduction followed by oxidation of the C2 alcohol to give ketoepoxide 180. 
Subsequent removal of the silyl protecting groups is expected to be 
followed by cyclisation to form the pyran and hemiacetal rings to give 
phomactin A. 
To explore either of these two potential routes, it will first be 
necessary to bring material through the route that has already been 
established within the group. The vinyl iodide side chain is made in four 
steps starting with a one-pot Swern/Wittig of 4-pentyn-1-ol to give ester 
182 followed by reduction with DIBAL-H at -78 ºC to give allylic alcohol 
183. 
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Reactants and Reagents: ai) DMSO, (COCl)2, Et3N, DCM, -78 ºC –r.t. ii) 
Ph3P=Me(CO2Et), -78 ºC – r.t. 73%; b) DIBALH , DCM, -78 ºC, 71%; c.i) Cl2ZrCp2, 
AlMe3, DCM, 0 ºC – r.t.; c.ii) I2, THF, -30 ºC-r.t.; 80%  d) TBSCl, Imidazole, DCM, 
0 ºC – r.t. 95%. 
Scheme 58 
 
The alkyne moiety is then converted to the vinyl iodide incorporating a 
methyl group via a Negishi carboalumination followed by an iodine 
quench and the alcohol is subsequently protected as its TBS ether. 
Ortho-toluic acid will also need to be elaborated to the aldehyde 160 
via the established Birch reduction and 2,3-Still-Wittig pathway before 
addition of the side chain 161 via formation of the vinyl ytterbium species 
to give alcohol 162 as outlined below.44 
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Reactants and Reagents: a) Li, liq. NH3, THF, -78 ºC then MeI, 91%; b) AcCl, 
MeOH, r.t., 88%; c) PDC, celite, TBHP, C6H6, 0 ºC, 60%; d) CuI, MeLi, Et2O, 0 ºC, 
84%; e) TBS-OTf, Et3N, CH2Cl2, r.t.,72%; f) Trifluoroacetone, Oxone® , NaHCO3, 
Na2EDTA, CH3CN, H2O, 0 ºC, 65%; g) TBSCl, Imidazole, DCM, 0 ºC-r.t. 96%; h) 
NaBH4, CeCl3, MeOH, -78 ºC, 65%; i) TBDPSCl, Imidazole, DCM, 0 ºC – r.t., 86%; 
j) Super-Hydride, THF, 0 ºC, 80%; k) MsCl, Et3N, DCM, 0 ºC, 95%; l) PhSH, 
NaH, DMF, ∆, 72%; m) Ammonium molybdate, H2O2, EtOH, -20 ºC to r.t., 88%; n) 
Conc. HCl, EtOH, r.t., 90%; o.i) NaH, THF, r.t.;.ii) Bu3SnCH2I, 82%; p) n-BuLi, 
THF, -78 ºC, 64%; q) i-Pr2Net, Py.SO3, DMSO, DCM, 0 ºC, 90%; r) 161, t-BuLi, 1 
hour, Yb(Otf)3, 2 hours, THF, -78 ºC, 85%. 
Scheme 59 
 
The synthetic route is 18 steps with the only convergent step being the 
addition of the side chain 161 into the aldehyde 162. It is at this point that 
the alternative strategies can be investigated by first applying an 
alternative protecting group at C2, such as a TIPS or SEM group before 
elaborating to the macrocycle via formation of the primary allylic bromide 
and base induced macrocyclisation. 
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Scheme 60 
 
If the desired macrocycle is synthesised successfully, either of the two 
routes to phomactin A as already described could then be investigated. 
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Chapter 3. 
Synthesis of known alcohol 162  
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3.1 Birch reduction and introduction of the C12 methyl group. 
 
Very briefly, the chemistry which was repeated to bring material through 
the established route will be mentioned. To a solution of o-toluic acid 127 
in THF and condensed ammonia, was added lithium metal resulting in a 
deep blue solution. The radical anion species that is formed is protonated 
para to the carboxylate and then further reduced to the carbanion, which 
is subsequently quenched with methyl iodide at the carbon alpha to the 
carboxylate.45, 46 This forms the first quaternary centre present in all of 
the phomactins. Thus the Birch reduction establishes one of the 
quaternary centres and a 2,5-diene motif which allows for further 
manipulation. The reaction is amenable to large scale and can routinely be 
carried out on scales of 40g or more, returning very good yields which were 
comparable to previous results in the group and requires no further 
purification. 
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Reactants and Reagents: a) Li, liq. NH3, THF, -78°C then MeI, 97%; b) AcCl, 
MeOH, r.t., 89%. 
Scheme 61 
 
The carboxylic acid in 189 was then converted to the methyl ester using 
acidic methanol. To a solution of acetyl chloride in methanol at 0 ºC was 
added a solution of carboxylic acid 189 in methanol dropwise. Stirring 
overnight at room temperature gave the methyl ester 190 after work-up 
again in very good yield without the need for further purification. 
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3.2 Bis-allylic oxidation and cuprate addition. 
 
All the phomactins have a methyl substituent at C12. To introduce this, 
the bis-allylic position in 190 was first oxidised to a ketone so that a 
suitable methyl nucleophile can be added in a 1,4 fashion. 
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Reactants and Reagents: a) PDC, celite, TBHP, C6H6, 0°C, 66%; b) CuI, MeLi, 
Et2O, 0°C, 82%. 
Scheme 62 
 
To a slurry of ester 190, PDC and celite in benzene at 0 ºC was added 
TBHP dropwise and stirred at this temperature for one hour.47 The 
red/brown suspension was then stirred at room temperature overnight. 
After having decanted the reaction medium from the solids before work 
up, the dark brown residue obtained was recrystallised using hot 
petroleum ether to give ketone 128 as a light yellow solid. Previously 
within the group the crude product would be purified via silica 
chromatography, this alternative purification process gave product which 
was comparable in terms of purity and yield with the added benefit of not 
having to carry out expensive large scale silica chromatography. 
The dienone 128 was then subjected to a methyl cuprate addition 
which proceeded as expected to give enone 191 as a 3:1 mixture of 
diastereoisomers in favour of the desired stereoisomer. The reason for the 
facial selectivity observed from the cuprate addition is unclear. Using 
steric bias from the methyl ester as an explanation does not tally with 
experimental observation. McGowan investigated the cuprate addition on 
a number of esters of increasing steric bulk and showed there was very 
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little influence on the distribution of the two diastereoisomers observed. 
The observed facial selectivity must be due to more complex electronic 
interactions and would require a detailed study for an explanation. 
 
3.3 Oxidation of the C20 methyl. 
 
Having installed the C12 methyl, the next objective was to oxidise the C20 
methyl and form an allylic alcohol. The most successful approach within 
the group was to form the conjugated silyl enol ether first and then oxidise 
the terminal olefin with a dioxirane to give the homoallylic alcohol 185 
required. 
 
191
O
O
O
192
O
O
O
TBS
a
 
Reactants and Reagents: a) TBS-OTf, Et3N, CH2Cl2, r.t.,88% 
Scheme 63 
 
Triethylamine and TBS triflate was added to a solution of enone 191 in 
DCM at 0 ºC. Workup and purification after 21 hours gave the expected 
silyl enol ether 192 in an acceptable 88% yield. The in situ generation of 
methyl(trifluoromethyl) dioxirane was then used to oxidise the terminal 
olefin.48  
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Reactants and Reagents: a) Trifluoroacetone, Oxone®, NaHCO3, Na2EDTA, 
CH3CN, H2O, -5 ºC, 49%. 
Scheme 64 
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Trifluoroacetone was added to a cold solution of the silyl enol ether 192 in 
acetonitrile and EDTA solution before adding a mixture of NaHCO3 and 
Oxone® portionwise. The reaction was complete in 45 min according to 
TLC and the desired allylic alcohol was isolated in a slightly lower than 
expected 49% yield after workup and purification. 
For this oxidation it is essential to maintain the pH between 7-7.5. 
The sulfate anion, a by-product from the formation of the dioxirane 
(Scheme 65) causes the lowering of the pH of the aqueous reaction media. 
A Bayer-Villiger reaction can result from the reaction of the 
peroxymonosulfate anion and the carbonyl group of the allylic alcohol 
under acidic conditions.49 
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Scheme 65 
 
By using an excess of base (NaHCO3), the neutrality of the reaction 
system can be maintained and the unwanted side reaction thus avoided. 
Presumably the reaction proceeds via initial epoxidation of the exocyclic 
olefin which upon work-up opens up to the allylic alcohol as the silyl enol 
ether collapses back to the enone.  
 
3.4 Attempts to functionalise at C1 
 
At this point an alternative approach to the established route was 
investigated. It was hoped that by functionalising what would be C1 in 
phomactin A, the route could be shortened by avoiding the [2,3]-Still 
Wittig reaction. Although this reaction establishes functionality at the C1 
position, the drawback is that the oxygen functionality at C20 is removed 
and then has to be reinstalled later in the synthesis. With this in mind, 
the possibility of functionalising the C1-C2 to bond in a different manner 
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which would allow the oxygen functionality at C20 to be kept in place was 
investigated. 
Forming the vinyl bromide from enone 52 was thought to be a 
potential entry into functionalising the C1 position akin to Halcomb’s 
bromination of enone 50.21 
 
 
Reactants and Reagents: a) NaBH4, CeCl3; b) m-CPBA, 81% for two steps; c) 
Dess-Martin periodinane, 86%; d) MgBr2·Et2O, 83%; e) TFAA, Pyr., 95%. 
Scheme 66 
 
The important point to note about the bromination of Halcomb’s is 
that a direct approach was not successful; hence a longer indirect 
approach through epoxide 51 was employed. An approach such as this 
would have to be avoided as any benefits of forming the vinyl bromide 
would be mitigated by the number of steps. Hence it was decided to 
attempt a direct approach initially on the less hindered enone 191 which 
is still to be oxidised at C20. 
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Reactants and Reagents: a) Br2 (1.1 eq), Et3N (5 eq) DCM, 0 ºC – r.t. – reflux. 
Scheme 67 
 
Bromine was added to a solution of enone 191 in DCM at 0 ºC followed by 
triethylamine.50 After 3 hours TLC indicated that no reaction had 
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occurred. The reaction was slowly warmed to reflux and after workup 
returned unreacted starting material. 
An alternative approach to form the C1-C2 bond was to form the 
extended enolate from enone 191 and trapping an aldehyde at the alpha 
position. It was hoped that the extended enolate would alkylate at the α 
position to leave the exocyclic double bond i.e. a deconjugative aldol 
reaction. The idea behind this approach was similar to the bromination; if 
the deconjugative aldol reaction was successful, we could look to couple to 
a suitably functionalised aldehyde. 
 Deconjugative aldol reactions are known in the literature on acyclic 
systems, for example the work done by Galatsis et al. in 1994 when trying 
to make cyclic ethers via a tandem deconjugative aldol cyclisation 
sequence.51 
 
Scheme 68 
 
For example the treatment of ethyl crotonate with LDA/HMPA at -78 ºC 
followed by exposure to benzaldehyde gave the homo-allylic alcohol ester 
as a mixture of diastereoisomers in 88% yield. The only product was the 
one derived from α-alkylation. It was hoped that this procedure could be 
applied to the cyclic system 191 to give a homo-allylic alcohol of the type 
195. 
 
Reactants and Reagents: a) i) LDA (1.5 eq), HMPA (1.5 eq) THF, -78 ºC, 30 
min. ii) benzaldehyde, -78 ºC, 30 min. 
Scheme 69 
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To a solution of LDA in THF at -78 ºC was added HMPA followed by enone 
191 and the solution was stirred at this temperature for 30 minutes before 
the addition of a solution of benzaldehyde in THF. The reaction was 
stirred for a further 30 minutes before being quenched with saturated 
ammonium chloride solution. Unfortunately, the reaction led to a complex 
mixture of inseparable compounds; hence, further investigation was 
abandoned. 
 
3.5 Synthesis of the [2,3]-Wittig-Still precursor. 
 
While these alternative possibilities were being investigated, a colleague 
took allylic alcohol 185 and carried it through a number of steps on the  
established route to the phenylsulfone 187 to give 39g of this 
intermediate. For clarity these steps are outlined below. The primary 
allylic alcohol was protected as its TBS ether, the ketone reduced via a 
Luche reduction (at which point the diastereoisomers are separated) and 
protected as the TBDPS ether to give ester 186. 
 
 
Reactants and Reagents: a) TBSCl, Imidazole, DCM, 0 ºC-r.t. 96%; b) NaBH4, 
CeCl3, MeOH, -78 ºC, 65%; c) TBDPSCl, Imidazole, DCM, 0 ºC – r.t, 86%; d) 
Super-Hydride, THF, 0 ºC, 80%; e) MsCl, Et3N, DCM, 0 ºC, 95%; f) PhSH, NaH, 
DMF, ∆, 72%; g) Ammonium molybdate, H2O2, EtOH, -20 ºC to rt, 88%. 
Scheme 70 
 
The ester was then converted to the sulfone via reduction to the primary 
alcohol using Super-Hydride, formation of the primary mesylate which 
was displaced by the sodium phenylthiolate and the resulting sulphide 
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oxidised to the sulfone using hydrogen peroxide ammonium molybdate to 
give 187 from which the synthesis of known alcohol 162 continued. 
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Reactants and Reagents: a) Conc. HCl, EtOH, r.t. 95%; b.i) NaH, THF, r.t.; 
ii) Bu3SnCH2I, 94%. 
Scheme 71 
 
The TBS group was selectively removed with concentrated HCl in ethanol 
to give the primary allylic alcohol 196. This was deprotonated with NaH 
and the resulting sodium alkoxide was quenched with 
iodomethyltributyltin 197, which was synthesised in two steps (from 
tributyltin hydride and paraformaldehyde followed by treatment of the 
alcohol with n-iodosuccinimide),52 to give the tributylstannylmethyl ether 
158 in excellent yield. 
 
With the formation of the tributyltinmethyl ether 158, the synthesis was 
set to take a key step in the [2,3]-Wittig rearrangement. 
 
3.6 The [2,3]-Wittig rearrangement. 
 
PhSO2
OTBDPS
O SnBu3
PhSO2
OTBDPS
OH
H
a
158 159  
 
Reactants and Reagents: a) n-BuLi, THF, -78 ºC; 60%. 
Scheme 72 
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The reaction involves the slow addition of 2.25 equivalents of n-BuLi (the 
low pKa of the α sulfone protons means the rearrangement occurs on the 
dianion) to a solution of the stannylmethyl ether at -78 ºC. Tin-lithium 
exchange is followed by a slow [2,3]-sigmatropic rearrangement to give the 
homoallylic alcohol 159 upon work-up. 
The stereochemistry of the newly formed chiral centre at C-1 can be 
rationalized via consideration of the transition state (Figure 11) given 
below. 
 
OP
SO2Ph
O
Li
Li  
Figure 11 
 
The six membered, transient, chelating ring can direct to the lower face of 
the olefin that is orbitally disposed to axial attack to give the 
stereochemistry of C-1 presented in 159. 
 
3.7 Synthesis of the C3-C9 side chain fragment. 
 
At this point attention was turned to the synthesis of the side chain 
fragment.  
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Reactants and Reagents: a .i) DMSO, (COCl)2, Et3N, DCM, -78 ºC -r.t. a .ii) 
Ph3P=Me(CO2Et), -78 ºC - r.t. 73%; b) DIBALH , DCM, -78 ºC, 71%; c.i) Cl2ZrCp2, 
AlMe3, DCM, 0 ºC – r.t.; c.ii) I2, THF, -30 ºC-r.t.; 80%  d) TBSCl, Imidazole, DCM, 
0 ºC – r.t. 95%. 
Scheme 73 
 
The commercially available alcohol 181 was converted to the E-α,β 
unsaturated ester 182 by a one pot Swern-Wittig reaction. Reduction of 
the ester was carried out using DIBAL-H to give the allylic alcohol 183. 
The alkyne moiety of 183 was then converted to the cis-vinyl iodide 184 
via a hydrozirconation/iodination reaction catalysed by the zirconocene 
derivative Cl2ZrCp2.53 To a solution of the zirconocene derivative and 
trimethylaluminium was added a solution of the alkyne 183 and the 
resulting lemon yellow reaction mixture stirred at 0 ºC for 30 min before 
warming to room temperature and stirring overnight. It is thought that 
the reaction proceeds via one metal activating the other and a concerted 
addition of the methyl group and the aluminium species results in the 
trisubstituted vinyl aluminium species that has the two new substituents 
cis. 
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R = (CH2)2CH2(Me)CH2OTBDPS 
X = Cl or Me 
Figure 12 
 
After 24 hours, TLC analysis indicated the complete consumption of the 
starting material and the reaction was quenched with a solution of iodine 
in THF forming the vinyl iodide and retaining the geometry of the double 
bond to give 184 in good 80% yield. Previous workers had got varying 
yields of between 50-65%, this was possibly due to the quality of the 
zirconocene catalyst, as the older the batch of catalyst, the longer the first 
step of the concerted addition seems to take, suggesting the catalyst 
degrades relatively quickly. TBS protection of the primary alcohol 
proceeded smoothly to give the completed side chain fragment 161. 
Having prepared the side chain, the homoallylic alcohol 159 
resulting from the 2,3-Still-Wittig rearrangement was oxidised to the 
aldehyde 160 using Parkih-Doering conditions.54  
 
159
aPhSO2
OTBDPS
OH
H
PhSO2
OTBDPS
O
H
160  
 
Reactants and Reagents: a) i-Pr2NEt, Py.SO3, DMSO, DCM, 0 ºC, 95%. 
Scheme 74 
 
To a solution of the alcohol 159 in DCM at 0 ºC was added DIPEA followed 
pyridine sulphur trioxide complex and DMSO. TLC indicated the reaction 
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had gone to completion within fifteen minutes. After workup and 
purification, the aldehyde was isolated in 95% yield. 
 
3.8 Side chain addition to the C2 aldehyde 
 
The use of organoytterbium reagents is the method of choice that has been 
utilised in the past to couple the side chain to the cyclohexenyl aldehyde 
core. The diastereoselective addition of organoytterbium reagents to chiral 
aldehydes and ketones was first reported by Molander who also observed 
the compatibility of these reagents with easily enolizable carbonyl 
compounds.55, 56 The group of Procter had demonstrated the use of these 
reagents in a trans-lactonisation reaction of the base sensitive chiral 
cyclobutanone 198 to give the bicyclic lactone 199, as part of their studies 
towards the synthesis of the immunosuppressant pestalotiopsin A.57  
   
O
O
OH
H
O
OH
R
H
H
O
198 199
a. i
ii
 
 
Reactants and Reagents: a) i. R-Li or R-MgBr. ii. Yb(OTf)3, THF, -78 ºC. 
Scheme 75 
 
When using organolithium or Grignard reagents for this reaction a 
substantial amount of epimerisation of the lactone α-stereogenic centre 
had been observed and the desired bicyclic lactone had been produced in 
low yield. However, upon transmetallation of the more conventional 
reagents with ytterbium triflate and subsequent treatment of 198 with the 
organoytterbium reagents the reaction proceeded to give the desired 
product in good yield and without any evidence of the epimerised by-
products. Ytterbium triflate is easily synthesised from ytterbium oxide 
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and triflic anhydride and then dried at 180 ºC under high vacuum 
overnight.58 
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Reactants and Reagents: a) i. t-BuLi ii. Yb(OTf)3 iii. 160, THF, -78 ºC 
Scheme 76 
 
Treatment of a solution of vinyl iodide 161 in THF at -78 ºC with one 
equivalent of t-BuLi gave the vinyl lithium species via halogen-lithium 
exchange. This solution was stirred for two hours at -78 ºC before 
transferring via cannula to a solution of ytterbium triflate in THF at -78 
ºC. This produced a clear deep red solution which was stirred at -78 ºC for 
30 minutes. Three equivalents of the organoytterbium reagent were then 
added via cannula to a solution of the aldehyde 162 in THF, also at -78 ºC, 
giving a pale red solution. This was then stirred at -78 ºC for 5 hours, 
which after workup and purification gave the secondary alcohol 162 
consistently in excess of 75% yield. The observed stereochemistry in the 
adduct 162 can be explained due to the carbonyl oxygen and the TBDPS 
protected oxygen at C14 chelating the organometallic counter ion to give 
the anti-Felkin-Anh adduct (Figure 13). 
 
O
O
M
H
R3Si
H
H
SO2Ph
Me
Me
Nu
 
Figure 13
 90 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4. 
C2 Protection and Macrocyclisation 
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4.1 Protection of the C2 alcohol 
 
Having synthesised the known secondary alcohol 162, attention was 
turned to protecting the C2 alcohol with alternative protecting groups to 
what had previously been employed within the group. Initial attempts 
focused on protecting the C2 alcohol as its TIPS ether. 
 
 
P = TBDPS 
Reactants and Reagents: a) TIPSCl, Imidazole, DCM, r.t. 
Scheme 77 
 
To a solution of the alcohol 162 in DCM at room temperature, was added 
imidazole followed by TIPSCl. The reaction was stirred at room 
temperature overnight, TLC analysis showed unreacted starting material 
present with no indication of a new product so the reaction was warmed to 
reflux and stirred for a further 24 hours. TLC once again showed 
unreacted starting material with no discernible presence of a new product. 
Assuming that the alcohol was not sufficiently reactive enough, the more 
vigorous TIPSOTf was then used in attempt to obtain the TIPS ether.40 
 
 
P = TBDPS 
Reactants and Reagents: a) TIPSOTf, 2,6-lutidine, DCM, -78 ºC – 0 ºC. 
Scheme 78 
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To a stirred solution of the alcohol and 2,6-lutidine in DCM at -78 ºC was 
added TIPSOTf and the reaction allowed to warm to 0 ºC. After 4 hours, 
TLC indicated the complete consumption of the starting material and the 
presence of a new less polar product. 
1H NMR analysis of the less polar product showed no evidence of 
the incorporation of a TIPS group and surprisingly showed the presence of 
extra peaks in the vinyl region. Mass spec data suggested the presence of 
a compound that was 18 mass units lighter than the starting material 
which would suggest that in fact H2O was eliminated across the C1-C2 
bond and would explain the extra signals in the vinyl region of the 1H 
NMR spectrum. 
Having been unable to synthesise the TIPS protected ether, 
attention shifted to using a different class of silicon protecting group. It 
was felt a SEM ether maybe a suitable alternative. 
 
 
P = TBDPS 
Reactants and Reagents: a) SEMCl, DIPEA, TBAI, DCM, r.t., 3 days, 94%. 
Scheme 79 
 
The addition of SEMCl to a solution of alcohol 162 and DIPEA in THF was 
followed by addition of tetrabutylammonium iodide. The resulting pale 
yellow solution was stirred at room temperature. A slow protection ensued 
which, after 3 days, had gone to completion according to TLC. Upon 
workup and purification, the desired SEM ether 202 was isolated as a 
clear oil in 94% yield. The IR spectrum confirmed the disappearance of the 
alcohol functionality, 1H NMR showed the presence of a 2 proton AB 
system at 4.17 and 4.36 ppm respectively indicating the presence of the 
OCH2O of the SEM group along with other characteristic signals for the 
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SEM group. Mass spec data also correlated with the expected mass of the 
product. 
 
4.2 Macrocyclisation 
 
With the SEM protected material 202 in hand, the next objective was to 
take it through to the macrocycle. 
 
 
P = TBDPS 
Reactants and Reagents: a) AcOH: THF: H2O, 3:1:1, rt, 82%; b) MsCl, Et3N, 
LiBr, THF, 0 ºC, 93%. 
Scheme 80 
 
The primary allylic TBS group was selectively deprotected using a mixture 
of acetic acid, THF and water (3:1:1) to give the primary allylic alcohol 
203. 1H NMR confirmed the disappearance of the TBS group while 
showing that both the SEM and TBDPS groups were still present. IR 
showed the presence of alcohol functionality with strong absorption at 
3531 cm-1 and accurate mass matched what was expected for the product. 
The alcohol was then converted to the allylic bromide 188 via the in situ 
generation of the mesylate, which was then displaced with a solution of 
lithium bromide.59 Formation of the mesylate took over an hour while 
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displacement with LiBr was a fairly quick process at 0 ºC as consumption 
of the mesylate occured in 20 min according to TLC and the desired allylic 
bromide 188 was recovered from the reaction in 92% yield. Low resolution 
mass spec gave two peaks at 917 and 915 which corresponded to the mass 
plus the sodium ion of the two isotopes of bromine. IR showed no 
absorption in the alcohol region and accurate mass (915.3480) fitted with 
the expected mass of the bromide. 
Having synthesised the primary allylic bromide 188, the stage was 
set to form the macrocycle present in phomactin A via formation of the 14 
carbon macrocyle 174. 
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Reactants and Reagents: a) NaHMDS, THF, 0 ºC, 82% 
Scheme 81 
 
To a solution of the allylic bromide 188 at 0 ºC was slowly added NaHMDS 
over a period of 40 minutes. An intramolecular cyclisation ensued which 
went to completion over a period of 30 minutes as shown by TLC to give 
the desired product in 82% yield. Inspection of the 1H NMR showed that 
the reaction had produced a single diastereoisomer and the 2D COSY 
NMR showed a strong coupling interaction between the C10 sulfone 
proton and the C9 protons. Previous workers from these laboratories had 
obtained a crystal structure of the analogous BOM protected macrocycle 
163 that indicated the observed stereochemistry of the sulfone for this 
reaction and confirmed the C2 stereochemistry of the organometallic 
addition.42 The proton at the foot of the sulfone appears as a triplet in the 
1H NMR at 2.93 ppm which compares with 2.87 ppm in the analogous 
BOM protected macrocycle. 
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Having achieved the first objective of synthesising an analogous 
macrocycle, attention moved to applying the TPAP oxidation which would 
be expected to oxidise the C14 alcohol, oxygenate the exocyclic methylene 
and shift the double bond to the internal position. As previously discussed, 
the objective would then be to look at doing a regio- and stereo-selective 
epoxidation after removing the sulfone. This would take us to the epoxy-
alcohol 176 where the direction of the synthesis was envisaged. 
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Chapter 5. 
Selective epoxidation precursor  
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5.1 C14 deprotection and TPAP oxidation. 
 
The TBDPS protecting group was cleanly removed using TBAF at 35 ºC to 
give the secondary alcohol 205 in 85% yield. 
 
 
Reactants and Reagents: a) TBAF, THF, 35 ºC, 85%; b) TPAP, NMO, 4 Å MS, 
DCM, r.t. 74%. 
Scheme 83 
 
The alcohol was then subjected to the TPAP/NMO oxidation procedure and 
returned the ene-ketoaldehyde 206 as expected. Addition of NMO and 
TPAP to a mixture of the alcohol and 4 Å molecular sieves in DCM led to 
the formation of a black solution. This was stirred for 1.5 hours at room 
temperature giving rise to a single discrete less polar product according to 
TLC. Upon workup and purification, the product was obtained as a viscous 
yellow oil. 
The interesting aspects observed in the spectral data for this 
compound were the appearance of a 1 proton singlet at 10.6 ppm in the 1H 
NMR confirming the presence of an aldehyde, and the disappearance of 
the two singlets usually found between 5.0 and 6.1 ppm suggesting the 
∆15,20 olefin had gone. The loss of the C1 proton was evidence for formation 
of the ∆1,15 olefin and loss of the C14 proton suggested the formation of the 
C14 carbonyl group. On inspection of the 13C-NMR spectrum two distinct 
peaks in the carbonyl region confirmed the formation of a dicarbonyl 
compound and the mass spectrum fitted with the ene-ketoaldehyde 206. 
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There are only two reported examples of an analogous transformation 
using TPAP and NMO. Cholesterol derivatives of the type 207 (Scheme 
84) when subjected to TPAP/NMO resulted in an enedione However, a 
notable difference was the application of ultrasound during the reaction in 
attempt to increase the rate of oxidation of the alcohol which the authors 
of one paper reported was the cause of overoxidation.60, 61  
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Reagents and conditions: a) TPAP, NMO, 4 Å MS, 10% CH3CN/DCM, rt, 15%. 
Scheme 84 
 
5.2 Mechanistic aspects of the TPAP oxidation 
 
The mechanism of the TPAP oxidation (sometimes called the Ley 
oxidation) of alcohols is complex and the precise nature of the species 
involved in the catalytic cycle is unknown. The difficulty arises because of 
the large range of oxidation states ruthenium can occupy, ranging from -2 
to +8. Complexes of RuVIII, RuVII, RuVI, RuV and RuIV can all 
stoichiometrically oxidise alcohols to aldehydes or ketones.62 
Some have suggested that the oxidation proceeds via the formation 
of a complex between the alcohol and TPAP (ruthenate ester). While it is 
known that one electron oxidants will cleave cyclobutanol to acyclic 
products, it has been shown that catalytic TPAP with NMO as co-oxidant, 
will oxidise cyclobutanol to cyclobutanone in very high yield suggesting 
that the oxidation processes involved are of the two-electron type.63 It 
suffices to say that a more detailed study is required of the processes 
involved before a mechanism for the TPAP oxidation can be elucidated. 
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5.3 Reduction of the ketoaldehyde and sulfone removal 
 
The ene-ketoaldehyde was then subjected to a DIBAL-H reduction to give 
the diol. 
 
 
Reagents and conditions: a) DIBALH, DCM, -78 ºC, 66%. 
Scheme 85 
 
Slow addition of DIBAL-H to a solution of the ketoaldehyde in DCM at -78 
ºC led to complete consumption of the starting material in 2 hours. TLC 
analysis showed the presence of an intense polar spot accompanied with a 
number of minor components. The major product was isolated and 
assigned as the diol with stereochemistry at C14 as represented by 
analogy to previous work. The 1H NMR spectrum was characterised by 
loss of the aldehyde peak, the appearance of a 1 proton triplet of doublets 
at 4.32 ppm was evidence for the proton at the foot of the C14 alcohol, IR 
showed strong absorption at 3485 cm-1 which was evidence for the 
presence of alcohol functionality and also confirmed that there was no 
carbonyl functionality remaining. It is believed that the reducing agent 
approaches from the face opposite the macrocycle ‘belt’ and sulfone leading 
to reduction from the ‘top’ face and the observed stereochemistry. 
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Figure 13 
 
Before attempting to per-acetylate the diol 175 in order to try to 
deactivate the olefin in the cyclohexene towards epoxidation in subsequent 
steps, it was necessary to remove the sulfone. Previous work in these 
laboratories had shown that sodium in liquid ammonia cleanly removed 
the sulfone in similar substrates. 
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Reactants and Reagents: a) NH3, Na, EtOH, THF, -78 ºC. 
Scheme 86 
 
When applying these conditions to macrocycle 175 however, a mixture of 
compounds was observed with none of the desired compound isolable. The 
only compound that was isolated seemed to be the over reduced product 
209 where the OSEM group had also been cleaved. The 1H NMR clearly 
showing the disappearance of the C2 proton that is normally seen at the 
foot of the OSEM group and the disappearance of the signals normally 
expected for the SEM. The 2D COSY showed strong coupling between the 
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C3 vinyl proton and a 2 proton multiplet. Mass spectral data also fitted 
with the over reduced product. 
The only procedure which was found to give some of the desired 
compound was sodium amalgam in methanol.64, 65 
 
 
Reactants and Reagents: a) Na/Hg (10%), MeOH, 0 ºC, 20%. 
Scheme 87 
 
However, the reaction was poor yielding, capricious and difficult to purify 
to a satisfactory level. Attempts to try and optimise the reaction were 
unsuccessful. Undeterred, it was decided to leave the sulfone appendage 
and attempt to remove it further on in the synthesis. 
 
 
Reactants and Reagents: a) Ac2O, Et3N, DMAP, DCM, r.t., 80%; b) 
MgBr2.(OEt)2, n-BuSH, NaHCO3, Et2O, 30%. 
Scheme 88 
 
To a solution of the diol 175 in DCM at 0 ºC, was added triethylamine 
followed by acetic anhydride and DMAP. The reaction was then allowed to 
stir overnight. Upon workup and purification, the bis-acetate 211 was 
isolated in 80% yield. The C14 proton shifted quite significantly in the 1H 
NMR to 5.48 ppm and appeared as a simpler 1 proton triplet, the 
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appearance of two 3 proton singlets around 2.00 ppm were evidence for 
incorporation of the acetates. The 13C NMR confirmed the presence of two 
carbonyl carbons and IR confirmed the loss of alcohol functionality. As 
previously mentioned, the objective of the acetates was to act as electron 
withdrawing groups to deactivate the ∆1,15 olefin compared to the ∆3,4 
olefin towards directed epoxidation. 
Having masked the alcohols as the acetates, the next objective was 
to remove the SEM group before the epoxidation could be attempted. 
Magnesium bromide diethyl etherate, potassium carbonate and n-
butanethiol were added to a solution of the SEM ether 211 in diethyl 
ether.66, 67 The reaction proceeded to give a complex mixture of inseparable 
compounds. The potassium carbonate in the reaction is normally added to 
‘mop up’ any HBr that maybe formed in the reaction, it maybe possible 
that the potassium carbonate was interfering with the acetate groups by 
causing base-induced elimination which led to the complex mixtures.  
When the reaction was carried out with sodium hydrogen carbonate 
as the base, after 24 hours at room temperature a new more polar product 
was evident by TLC, albeit very faint and still a large amount of unreacted 
starting material. Upon work-up and purification, the new compound 
isolated was found to be the desired deprotected alcohol 212 in 30% yield. 
The peaks normally found in the 1H NMR for the SEM group were no 
longer present, IR showed strong absorption in the alcohol region and the 
mass spectrum fitted for the alcohol. Attempts to optimise this result by 
increasing the reaction time, equivalents of reagents and increasing the 
temperature all led to slow decomposition of the substrate. 
Various other procedures were used in an attempt to improve on the 
SEM deprotection. The use of HF.py,68 or concentrated HCl in methanol69 
returned unreacted starting material, whereas the use of magnesium 
bromide etherate with nitromethane led to decomposition. The difficulty in 
removing the SEM group efficiently was a frustrating hurdle because, 
what should be a simple transformation was proving to be a serious 
roadblock. Before abandoning this route and attempting the alternative 
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route described earlier, it was felt it would be prudent to try and see if the 
selective epoxidation would work on the 5 mg of the alcohol 212 that was 
available. 
 
5.4 Regio- and stereoselective epoxidation of carbinol 212 
 
When looking to epoxidise the ∆3,4 olefin, the stereochemistry of the ∆3,4 
epoxide has to have the correct β-orientation as this sets the 
stereochemistry for the C3 secondary alcohol. It was expected that this 
could be accessed through epoxidation directed through the C2 secondary 
alcohol utilising VO(acac)2/TBHP reagent system analogous to the 
epoxidation used in the Pattenden synthesis of phomactin A.70-72 
 
 
Figure 14 
 
The use of transition metal-catalysed tert-butyl hydroperoxide 
epoxidations were first described by Indictor and Brill.73 The application of 
molybdenum hexa-carbonyl as an efficient catalyst for many different 
olefin types and vanadyl acetyl acetonate as an excellent catalyst 
especially for allylic alcohols soon followed.74 In the case of dienols, these 
studies showed the vanadium complex was regioselective for the olefin of 
the allylic alcohol whereas the molybdenum complex showed a complete 
lack of regioselectivty. A mechanism based on these observations was 
proposed which involved the formation of an allylic alcohol, vanadium and 
peroxide complex before epoxidation could take place. Sharpless et al. 
probed this hypothesis by carrying out epoxidation reactions in the 
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presence of 18O-enriched water.75 The absence of 18O in the epoxide 
products of these reactions led to the conclusion that intact alkyl 
hydroperoxide is present in the epoxidising peroxo complex rather than a 
peroxo complex formed by the elimination of tert-butanol. These 
observations led to a refined proposal of the possible catalytic mechanism 
of this reaction of which the details are outlined below (Scheme 89). 76 
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Scheme 89 
 
TBHP oxidises the VO(acac)2 complex A to a catalytically active d0 
vanadate ester (VO(OR)3) which undergoes rapid ligand exchange to give 
B. Bidentate coordination of the alkyl peroxide results in the active 
epoxidising complex C which undergoes nucleophilic attack by the olefin 
in the rate determining step to yield the epoxy alcohol complex D. 
Dissociation to the products is followed and re-entry of the vanadium 
species to the catalytic loop. 
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Reagents and conditions: a) VO(acac)2; TBHP, C6H6, r.t., 55%. 
Scheme 90 
Initially the reaction was carried out using 1.0 equivalent of TBHP and 10 
mol.% of the vanadium catalyst in order to try and ensure selectivity for 
what would expected to be the more reactive olefin. Dropwise addition of 
the oxidant to a solution of the macrocycle and the catalyst in benzene 
resulted in a deep wine red solution. TLC analysis indicated a major, more 
polar product spot and some starting material still present after 20 
minutes. Another 0.5 equivalents of oxidant was added and the reaction 
stirred for a furter 30 min at which point TLC indicated almost complete 
consumption of starting material and still one major product spot 
although slightly more streaky. After work-up and purification the 
product was given in 55% yield as a clear oil. The 1H NMR revealed a 
single diasteroisomer which suggested the ∆15,20 epoxide had been formed 
exclusively. The C3 olefin proton which appears as 1 proton doublet at 
5.30 ppm in the epoxidation precursor had shifted to 2.89 ppm in the 
product which was evidence for disappearance of the ∆3,4 olefin and a 
strong indication of a proton at the foot of an epoxide. The evidence that 
could be gleaned for the ∆1,15 olefin still being present was the fact that the 
2 proton AB system for the C20 CH2 had not shifted as would have been 
expected had epoxidation occurred at the ∆1,15 olefin. Mass spectral data 
also concurred with the incorporation of only one epoxide. 
Although progress had been made, showing that the? regio and 
stereo-selective epoxidation was possible, the inefficiency of removing the 
SEM group meant the viability of this route became difficult to justify and 
a rethink was required. It was decided to go back earlier into the synthetic 
sequence and try and remove the SEM protecting group just after the 
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macrocyclisation and implement the epoxidation before the TPAP 
oxidation/rearrangement reaction, i.e. the alternative of the two routes 
that was discussed earlier. 
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Chapter 6. Early epoxidation  
 108 
6.1 SEM deprotection and epxidation 
 
Taking macrocycle 174 and refluxing in TBAF was found to be the best 
way to deprotect the SEM protected alcohol. 
 
 
Reactants and Reagents: a) TBAF, THF, reflux, 3 days, 55%. 
Scheme 91 
 
The reaction worked relatively well on a small scale (<20 mg) and gave a 
yield of approximately 55%. However, on increasing the scale the reaction 
was more sluggish and gave slightly lower yields. This procedure, as 
expected, also deprotected the C14 TBDPS group. 1H NMR confirmed that 
the two protecting groups had been removed as proton signals for both 
groups had disappeared. IR showed strong absorption at 3445 cm-1 
confirming the presence of alcohol functionality and mass spectral data 
fitted for the diol. 
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Reagents and conditions: a) VO(acac)2; TBHP, C6H6, rt, 75%. 
Scheme 92 
 
Application of the epoxidation protocol on diol 214 with the previously 
described procedure, cleanly gave mono-epoxide 215 in 75% yield with no 
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sign of over epoxidation on the exocyclic olefin as expected. 1H NMR 
showed that the C3 proton had shifted to 2.85 ppm which was evidence for 
disappearance of the ∆3,4 olefin while the two one proton singlets for the 
exocyclic olefin were still present at 5.58 and 5.20 ppm respectively. Mass 
spectral data also fitted for the mono-epoxide. 
With the epoxide installed at this earlier stage, attention was 
shifted to the TPAP oxidation/rearrangement reaction to install the 
oxygen functionality at C20 and shift the exocyclic olefin to the internal 
position as found in the natural product. However, before applying the 
TPAP procedure, it was necessary to protect the C2 alcohol to avoid 
oxidation at this position. What followed was a protection/deprotection 
sequence to provide the required substrate. 
 
 
Reagents and conditions: a) TBSCl, imid., DCM, RT, 92%; b) KHMDS, BnBr, 
TBAI, THF, -78 ºC – RT, 98%. 
Scheme 93 
 
TBS protection, using TBSCl and imidazole at room temperature was 
selective for the C14 alcohol. 2D COSY NMR showed that the C2 proton 
coupled with the C1 and C3 protons as expected but also showed coupling 
to a 2 H multiplet that contained one of the C9 protons and the free 
alcohol (2.42-2.48 ppm). The C2 alcohol in macrocycle 216 was then 
protected as the benzyl ether. To a solution of secondary alcohol 216 in 
THF at -78 ºC was added KHMDS followed by benzyl bromide, after 
warming to room temperature, an equivalent of tetrabutyl ammonium 
iodide was added and stirred at room temperature for sixteen hours. After 
workup and purification, the bis-protected macrocycle 178 was obtained in 
98% yield. Mass spectral data was in agreement with the expected mass 
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for the product and 1H NMR showed the incorporation of an extra five 
aromatic protons and a 2 proton ab system at 4.68 and 4.52 ppm 
respectively corresponding to the benzylic protons. 
 
6.2 Synthesis of epoxy-ketoaldehyde 
 
The benzyl group was chosen not only because it was orthogonal to the 
C14 TBS protected alcohol, but also because it was felt it could be removed 
simultaneously with the sulfone later on, cutting down the number of 
steps which have been increased due to the protection/deprotection 
sequence. 
 
 
Reagents and conditions: a) TBAF, THF, RT, 85%; b) TPAP, NMO, 4 Å MS, 
DCM, r.t. 70%. 
Scheme 94 
 
The TBS group was removed cleanly using TBAF to give the precursor 217 
for the TPAP oxidation. The epoxy-alcohol was taken and subjected to the 
TPAP conditions as previously described to give the ketoaldehyde 218 
where the double bond has also shifted to the internal position. 1H NMR 
data fitted well with the compound showing a 1 proton singlet at 10.52 
ppm corresponding to the aldehyde proton and disappearance of the C14 
proton which was evidence for formation of the ketone. 13C NMR 
confirmed the presence of two carbonyl groups and accurate mass fitted 
with the transformations carried out. 
 111 
Having synthesised the keto-aldehyde with the epoxide functionality in 
place, the full carbon skeleton as well as oxygen functionality at all the 
required positions has been achieved. 
 
 
Scheme 95 
 
Reduction of the carbonyl groups should lead to the diol with the correct 
stereochemistry at C14 as reduction should occur from the less hindered 
‘top’ face. All that would then be required would be to protect the diol so 
that the benzyl and sulfone could be removed and the C2 alcohol oxidised 
to the ketone leaving a global deprotection and cyclisation of the pyran 
and hemi-acetal rings to give phomactin A. 
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Reagents and conditions: a) DIBAL-H, DCM, -78 ºC to -60 ºC, 42%. 
Scheme 96 
 
Slow addition of DIBAL-H to a solution of the keto-aldehyde 218 in THF 
at -78 ºC gave a pale yellow solution which was then stirred at -60 ºC for 
1.5 hours. After workup and purification, the major product was isolated 
and assigned as the diol-epoxide 179. 1H NMR showed the appearance of a 
1 proton multiplet at 4.05 ppm which corresponded to the C14 proton. 2D 
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COSY NMR showed this to be coupling to a 1 proton doublet at 1.28 ppm 
which represented the C14-OH giving evidence for the non-formation of 
the pyran ring by opening of the epoxide by the C14 alcohol. Mass spectral 
data also agreed with the expected mass for the product. 
With only approximately 4.0 mg of the diol epoxide available at this 
point, an attempt to protect both alcohols as the TES ethers was made.77 
 
 
Reagents and conditions: a) TESOTf, 2,6-lutidine, DCM, -78 ºC to rt. 
Scheme 97 
 
To a solution of the diol in DCM at -78 ºC, was added 2,6-lutidine followed 
by addition of TESOTf. The reaction was then allowed to warm to room 
temperature. After one hour at room temperature, TLC indicated complete 
consumption of starting material and the formation of two new less polar 
products. It was assumed that the two new spots on the TLC plate 
corresponded to the products where only mono-protection had taken place 
and the less polar of the two being the product where bis-protection had 
taken place. Hence, the reaction was allowed to continue to stir overnight 
to try and push completion to the bis-protected product. 
TLC after stirring overnight showed very little change to the state 
of the reaction so it was worked up and purified on silica in an attempt to 
isolate the products. The more polar of the two compunds gave a mass-
spectral peak which corresponded to a product which had two TES groups 
incorporated, which was encouraging. The less polar compound which 
looked like one spot on TLC, actually turned out to be a mixture of 
compounds according to the 1H NMR spectrum. 
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Through these endeavours, we have been able to show that it is not only 
possible to carry out a difficult selective epoxidation to give advanced 
intermediate 174 but to also incorporate the epoxide earlier and take the 
synthesis through to advanced intermediate 179. Both these 
intermediates contain the full carbon skeleton and oxygen functionality 
required in phomactin A 1. However, due to lack of time, these 
investigations could not be taken any further. 
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Chapter 7. Conclusion  
 115 
7.1 Summary 
 
The preceding chapters have described the synthetic approaches 
undertaken towards the total synthesis of phomactin A, which can be 
summarised as follows. The first segment is concerned with the synthesis 
of the known secondary allylic alcohol 162 and then development to the 
SEM protected macrocycle 174. The second concerns itself with the 
development of the macrocycle and the attempts that were made to 
introduce the necessary functionality into the molecule. 
 
 
Figure 21 
 
The bis-protected macrocycle 174 which was envisaged to be a key 
intermediate in the phomactin synthesis can be efficiently synthesised 
from sulfone 187. Development of the alcohol 162 to bromide 188 was 
followed by an extremely efficient macrocyclisation reaction to give the 
macrocycle 174. 
 After deprotection of the C14 alcohol, the TPAP oxidation/reduction 
sequence gave the diol 175 with the ∆15,20 olefin shifting to become the ∆1,15 
olefin. Attempts to remove the sulfone appendage at this stage proved to 
be a problem and focus shifted to try and incorporate the ∆3,4 epoxide 
selectively over the ∆15,20 epoxide into the carbinol 175 via directed 
epoxidation from the C2 alcohol. Bis-acetylation of the diol 175 was 
followed by attempts to remove the SEM group to allow directed 
epoxidation. Unfortunately efficient removal of the SEM group turned out 
to be an unexpected hindrance; the epoxidation was attempted using 
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VO(acac)2 and TBHP on a small scale and the spectroscopic data strongly 
suggested that the epoxidation was selective for the ∆3,4 olefin. 
 
 
Scheme 98 
 
The inefficiency of removing the SEM group however meant the 
alternative approach whereby the epoxide is incorporated before the TPAP 
epoxidation had to be explored. Removal of the C14 and C2 protecting 
groups in macrocycle 174 was achieved by refluxing in TBAF and  
VO(acac)2/TBHP selectively epoxidised the ∆3,4 olefin. Following a 
protection/ deprotection sequence, alcohol 217 was subjected to the 
TPAP/DIBAL-H oxidation and reduction reactions to give epoxydiol 179. 
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The epoxydiol 179 has the full carbon framework of phomactin A and also 
has oxygen functionality at all the required positions. All that is required 
is to remove the benzyl group at C2 and the sulfone appendage before 
oxidising the C2 alcohol to the ketone which should lead to formation of 
the pyran and hemiacetal rings found in phomactin A. Before this though, 
it was necessary to protect the C20 and C14 alcohols, unfortunately the 
attempt at protecting the two alcohols as TES ethers using TESOTf/2,6-
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lutidine gave a mixture of compounds and the lack of time meant further 
investigations had to be ended at this point. 
 
7.2 Future work. 
 
The direction of future synthetic work will look to continue from the epoxy 
diol towards completion of phomactin A. 
  
 
P = TES 
Scheme 99  
 
It should be feasible to take epoxydiol 179 and protect the C14 and C20 
alcohols as the TES ethers. Although using TESOTf seems to be 
problematic, this could be down to the high reactivity of the silyl triflate 
which could be acting as a Lewis acid at the epoxide and causing 
unwanted side reactions. This could potentially be overcome by using less 
reactive TESCl. With the two alcohols protected it should be possible to 
remove the sulfone appendage and the C2 benzyl group using Na/NH3.78 
 
 
Scheme 100 
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Oxidation of the C2 alcohol followed by deprotection of the C14 and C20 
alcohol should lead to cyclisation of the pyran and hemiacetal rings to 
furnish phomactin A.  
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Chapter 8. Experimental 
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8.1 General experimental 
 
All reactions were carried out under an atmosphere of dry nitrogen unless 
otherwise stated. Temperatures quoted are those of the external bath in 
degrees Celsius (ºC).  
 
Low resolution mass spectral data were recorded on a Micromass Trio 200 
spectrometer; high resolution mass spectral data were recorded on a 
Kratos Concept, IS spectrometer. Modes of ionisation were electron impact 
(EI), chemical ionisation (CI) using ammonia, or electrospray in positive or 
negative mode (ES±). 
 
Melting points were performed on a Sanyo Gallenkamp melting point 
apparatus and are uncorrected 
 
Infrared spectra were recorded on a Genesis FTIR as evaporated films 
(from deuterochloroform or dichloromethane) on sodium chloride plates, 
and were quoted in wavenumbers as cm-1. 
 
Nuclear magnetic resonance spectra were performed using deuterated 
chloroform (CDCl3) as the solvent, unless otherwise stated. Proton nuclear 
magnetic resonance spectra (1H NMR) were recorded on a Bruker 
Ultrashield 500 (500 MHz), Varian INOVA 400 (400 MHz) or Varian 
INOVA Unity 300 (300 MHz) spectrometers. Residual non-deuterated 
solvent was used as the internal standard. Chemical shifts (δH) are quoted 
in parts per million (ppm) downfield from tetramethylsilane.  Signal 
splitting patterns are described as singlet (s), broad singlet (br s), doublet 
(d), triplet (t), quartet (q), doublet of triplets (dt) doublet of double doublets 
(ddd) or multiplet (m). Coupling constants (J) are quoted in Hertz (Hz). 
Carbon nuclear magnetic resonance spectra (13C NMR) were recorded on a 
Varian Unity 500 (125 MHz), Varian INOVA Unity 300 (75MHz) or 
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Varian Unity 400 (100 MHz) spectrometer. Chemical shifts (δC) are quoted 
in parts per million (ppm) downfield from tetramethylsilane. 
  
Flash column chromatography was carried out using Merck silica gel 60H 
(40-60nm, 230-300 mesh). Thin layer chromatography (TLC) was carried 
out using plastic plates coated with Merck HF254/366 silica gel. Detection 
was by ultraviolet absorption and/or treatment with either basic 
potassium permanganate or ethanolic phosphomolybdic acid followed by 
heating. 
 
Light petroleum refers to the fraction of light petroleum ether that distils 
between 40 ºC and 60 ºC at atmospheric pressure. Petrol was distilled 
from any higher boiling fractions before use. Ether refers to diethyl ether. 
Tetrahydrofuran was stored and dried over sodium/benzophenone and 
distilled under an atmosphere of nitrogen prior to use. Dichloromethane 
was dried over calcium hydride and distilled under an atmosphere of 
nitrogen prior to use. Benzene, toluene, ether and hexane were dried and 
stored over sodium wire. Triethylamine was stored over potassium 
hydroxide pellets. 
 
All other reagents and solvents were used as obtained or purified using 
standard techniques where necessary. 
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1,2-Dimethyl-2,5-cyclohexadiene-1-carboxylic acid, 189.39 
 
 
 
Freshly distilled ammonia (800 ml) was condensed into a rigorously dried 
three neck round-bottom flask containing ortho-toluic acid (40 g, 293.8 
mmol) and THF (160 ml) at -78 °C.  The rapidly stirred solution was 
cooled to -78°C. Lithium metal (finely chopped and rinsed with petrol) was 
added portion wise until a dark blue colour persisted for 15 minutes.  At 
this time, methyl iodide (36.32 ml, 583.4 mmol) was cautiously added via 
syringe. The resulting grey/off-white suspension was allowed to stir at  
-78 °C for a further 1.5 hours and was then allowed to warm to room 
temperature and stirred overnight.  The residue was taken up in water 
(700 ml) and acidified by the slow addition of concentrated hydrochloric 
acid. The aqueous solution was then extracted with diethyl ether (3 x 700 
ml). The organics were washed with saturated sodium thiosulphate 
solution (2 x 800 ml), brine (2 x 500 ml), dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the title compound 189 
(43.57 g, 97%) as a white solid, Rf = 0.25 (20% ether in petrol); δH (300 
MHz, CDCl3) 1.41 (3 H, s, 1-CH3), 1.76 (3 H, s, 2-CH3), 2.74 (2 H, m, 4-H2), 
5.62 (2 H, m, 3-H and 6-H) and 5.88 (1 H, dtd, J 10, 3, 1.5, 5-H); δC (125 
MHz, CDCl3) 19.7, 23.7, 26.8, 47.4, 121.8, 125.3, 128.9, 132.8 and 180.6; 
m/z (EI) 152 (M+, 15%), 107 (100) and 91 (81). 
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Methyl 1,2-Dimethylcyclohexa-2,5-diene-1-carboxylate, 190.39 
 
 
 
Acetyl chloride (30.53 ml, 429.4 mmol) was added dropwise to methanol 
(300 ml) at 0 °C.  The solution was stirred for 10 minutes before acid 189 
(43.57 g, 2886.3 mmol) in methanol (170 ml) was added in a dropwise 
manner.  The resulting colourless solution was allowed to warm to room 
temperature and stirred overnight. The solvent was then removed under 
reduced pressure and the residue was taken up in diethyl ether (500 ml), 
washed with saturated aqueous NaHCO3 (500 ml), brine (300 ml), dried 
(MgSO4), filtered and concentrated under reduced pressure to afford the 
title compound 190 (42.73 g, 89.8%) as a pale yellow oil, Rf = 0.5 (20% 
ether in petrol); (found: M+, 166.0993. C10H14O2 requires M, 166.0994); δH 
(300 MHz, CDCl3) 1.41 (3 H, s, 1-CH3), 1.75 (3 H, d, J 2, 2-CH3), 2.75 (2 H, 
m, 4-H2), 3.74 (3 H, s, 1-CO2CH3), 5.62 (2 H, m, 3-H and 6-H), 5.88 (1 H, 
dtd, J 10, 3, 1, 5-H); δC (125 MHz, CDCl3) 19.7, 24.0, 26.8, 47.5, 52.3, 
121.2, 124.5, 129.3, 133.3, and 175.3; m/z (CI) 166 (M+ + H, 30%). 
 
 
Methyl 1,2-Dimethyl-4-oxo-2,5-cyclohexadiene-1-carboxylate, 128.39 
 
 
 
A three neck round bottom flask fitted with a mechanical stirrer was 
charged with ester 190 (40.92 g, 246 mmol), benzene (800 ml), pyridinium 
dichromate (277.85 g, 738.5 mmol) and Celite (90 g). The resulting 
red/brown slurry was stirred and cooled to 0 °C.  At this temperature, tert-
butylhydroperoxide (70% w/v aqueous solution, 106.69 ml, 770.7 mmol) 
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was added dropwise.  The dark red slurry was stirred at 0 °C for 1 hour 
and then allowed to stir at room temperature overnight. After this time 
the solvent was decanted from the solids and diethyl ether (800 ml) was 
added to the remaining residue and stirred for 2 hrs. The suspension was 
filtered and the solids washed with further diethyl ether (300 ml), the 
combined filtrates (kept separate from the decanted benzene layer) were 
concentrated under reduced pressure to a volume of approximately 400 ml. 
Both the benzene and ether fractions were washed with saturated sodium 
metabisulfite solution (600 ml), water (500 ml), brine (500 ml), dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting 
residue was dissolved in the minimum amount of hot petroleum ether and 
allowed to cool to room temperature and then cooled further in ice. A 
powdery solid precipitated which was collected by filtration and washed 
with cold petrol and dried by drawing air through on vacuum filter to give 
the product 128 (29.46 g, 66%) as a pale yellow solid, Rf = 0.25 (ether in 
light petroleum, 1:5); (found: M+, 180.0787. C10H12O3 requires M, 
180.0786); δH (300 MHz, CDCl3) 1.55 (3 H, s, 1-CH3), 2.02 (3 H, s, 2-CH3), 
3.73 (3 H, s, 1-CO2CH3), 6.23 (1 H, d, J 1, 3-H), 6.34 (1 H, dd, J 10, 2, 5-H) 
and 6.82 (1 H, d, J 10, 6-H); δC (125 MHz, CDCl3) 20.3, 22.2, 51.6, 53.2, 
128.4, 128.8, 148.8, 157.8, 171.0 and 185.8; m/z (EI) 180 (M+, 25%), 136 
(60), 121 (100). 
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(1SR, 6RS)-Methyl 1,2,6-trimethyl-4-oxocyclohex-2-ene-1-
carboxylate,  191 β and (1SR, 6SR)-Methyl 1,2,6-trimethyl-4-
oxocyclohex-2-ene-1-carboxylate, 191 α.39 
 
 
 
 
Methyllithium (1.6 M in ether, 180 cm3, 288 mmol) was added drop wise 
via cannula to a suspension of copper (I) iodide (31.70 g, 166 mmol) in 
ether (550 ml) at 0 °C and the yellow suspension was stirred at 0 °C for 
two hours.  After this time, dienone 128 (20.0 g, 111 mmol) in ether (100 
ml) was added dropwise.  The suspension was allowed to stir for a further 
1.5 hours before adding saturated aqueous ammonium chloride : aqueous 
ammonia (500 ml, 1:1).  The mixture was partitioned with ether (300 ml) 
and the aqueous phase extracted with ether (400 ml). The organics were 
washed with water (500 ml) and brine (500 ml), dried (MgSO4), filtered 
and concentrated under reduced pressure. Chromatography of the residue 
on silica gel eluting with ether - light petroleum (1 : 10 → 2 : 5) afforded 
the title compounds 191 β and 191 α (17.84 g, 82%) as a 75 : 25 mixture of 
diastereoisomers.  Rf = 0.3 (ether in light petroleum, 1:1); (found: Μ+, 
196.1195. C11Η16Ο3 requires Μ, 196.1099); νmax/cm-1 2959, 2954, 1737, 
1730, 1670, 1628, 1438, 1240, 1190, 1167, 1115; δH for 191 β (300 ΜΗz, 
CDCl3) 0.97 (3 Η, d, J, 7, 6-CΗ3), 1.32 (3 Η, s, 1-CΗ3), 1.91 (3 Η, s, 2-CΗ3), 
2.23 (1 Η, dd, J 17, 13, 5-Η), 2.41 (1 Η, dd, J 17, 4, 5-Η’), 2.77 (1 Η, m, 6-
Η), 3.79 (3 Η, s, 1-CΟ2CΗ3), and 5.93 (1 Η, s, 3-Η); δH for 191 α (300 ΜΗz, 
CDCl3) 1.06 (3 Η, d, 7, 6-CΗ3), 1.32 (3 Η, s, 1-CΗ3), 1.94 (3 Η, s, 2-CΗ3), 
2.22 (1 Η, m, 6-Η), 2.36 (1 Η, dd, J 17, 5, 5-Η), 2.60 (1 Η, dd, J 17, 13, 5-
Η), 3.76 (3 Η, s, 1-CΟ2CΗ3) and 5.60 (1 Η, s, 3-Η); δC (125 ΜΗz, CDCl3) 
14.7, 16.5, 17.0, 20.5, 21.2, 21.4, 36.0, 38.3, 40.9, 42.2, 51.6, 52.2, 52.4, 
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52.5, 127.2, 128.5, 160.5, 162.8, 172.6, 174.9, 198.0 and 198.8; m/z (ΕΙ) 
196 (Μ+, 100%). 
 
 
(1SR,6RS)-Methyl 4-{[1-(tert-butyl)-1,1-dimethylsilyl]oxy}-1,6-
dimethyl-2-methylene-3-cyclohexene-1-carboxylate,  192 β and 
(1SR, 6SR)-Methyl 4-{[1-(tert-butyl)-1,1-dimethylsilyl]oxy}-1,6-
dimethyl-2-methylene-3-cyclohexene-1-carboxylate, 192 α.44 
 
 
 
 
Triethylamine (17.59 ml, 126 mmol) followed by tert-butyldimethylsilyl 
trifluoromethane sulphonate (28.05 ml, 122 mmol) were added at 0 °C to 
eneone 191 (15.98g, 81 mmol) in dichloromethane (190 ml). After 21 hours, 
the reaction was diluted with dichloromethane (300 ml) and washed with 
saturated aqueous sodium bicarbonate (300 ml). The organic layer was 
dried (MgSO4), filtered and concentrated under reduced pressure. The 
residue was dissolved in ether (300 ml) and separated from the insoluble 
triethylammonium trifluoromethane sulphonate. The ethereal solution 
was concentrated under reduced pressure. Chromatography of the residue 
on silica gel eluting with ether - light petroleum (2 : 100) afforded the title 
compounds 192 β and 192 α (22.36 g, 88%) as a 75 : 25 mixture of 
diastereoisomers, Rf = 0.7 (ether in light petroleum, 1:10); (found: Μ+ 
310.1961. C17Η30Ο3Si requires Μ, 310.1964); νmax/cm-1 2955, 2932, 2859, 
1733, 1644, 1463, 1371, 1254, 1196, 1107, 1000, 889, 839, 782; δΗ for 192 β 
(300 ΜΗz, CDCl3) 0.19 (6 Η, s, Si(CΗ3)2), 0.88 (3 Η, d, J, 7, 6-CΗ3), 0.95 (9 
Η, s, Si(CΗ3)3), 1.22 (3 Η, s, 1-CΗ3), 1.88 (1 Η, m, 5-Η), 2.20 (1 Η, m, 5-Η’), 
2.48 (1 Η, m, 6-Η), 3.73 (3 Η, s, 1-CΟ2CΗ3), 4.49 (1 Η, s, 2-CΗ), 4.71 (1 Η, 
s, 2-CΗ’) and 5.47 (1 Η, s, 3-Η); δΗ for 192 α (300 ΜΗz, CDCl3) 0.19 (6 Η, 
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s, Si(CΗ3)2), 0.95 (9 Η, s, Si(CΗ3)3), 1.05 (3 Η, d, J 7, 6-CΗ3), 1.44 (3 Η, s, 
1-CΗ3), 1.88 (1 Η, m, 5-Η), 2.20 (1 Η, m, 5-Η’), 2.48 (1 Η, m, 6-Η), 3.65 (3 
Η, s, 1-CΟ2CΗ3), 4.81 (1 Η, s, 2-CΗ), 4.87 (1 Η, s, 2-CΗ’) and 5.53 (1 Η, s, 
3-Η); δC (75 ΜΗz, CDCl3) -4.1, -4.1, -4.0, -3.9, 16.3, 17.1, 17.8, 18.3, 22.4, 
25.9, 25.9, 25.9, 34.7, 35.6, 37.0, 37.5, 48.7, 51.4, 51.8, 52.2, 107.0, 108.4, 
108.6, 109.6, 146.6, 147.8, 153.2, 153.8, 174.8 and 176.9; m/z (CI) 311 (M+ 
+ 1, 100%). 
 
(1SR, 6RS)-Methyl 2-(hydroxymethyl)-1,6,dimethyl-4-oxo-2-
cyclohexene-1-carboxylate, 185 β  and (1SR, 6SR)-Methyl 2-
(hydroxymethyl)-1,6,dimethyl-4-oxo-2-cyclohexene-1-carboxylate, 
185 α44 
 
 
 
 
Aqueous Na2EDTA (15.1ml, 4 x 10-4 M) was added to silyl enol ether 192 
(0.944g, 0.304 mmol) in acetonitrile (22 ml). The solution was cooled to 0 
oC, followed by addition of trifluoroacetone (3.04 ml, 33.44 mmol) via a 
pre-cooled syringe. A mixture of oxone (9.32g, 15.15 mmol) and sodium 
bicarbonate (1.97g, 23.37 mmol) was then added portion wise over a period 
of a half hour. After 45 min, the reaction mixture was filtered and 
extracted with dichloromethane (3x15 ml), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Chromatography of the residue on 
silica gel eluting with methanol in DCM (1 : 100 → 5 : 100) afforded the 
title compounds 185 β and 185 α (2.62 g, 49%) as a 75 : 25 mixture of 
diastereoisomers, Rf = 0.1 (ether in light petroleum, 3:10); νmax/cm-1 3422 
br, 2956, 2886, 1731, 1664, 1453, 1252, 1192, 1117, 1070 and 882; δH for 
185 β (300 MHz, CDCl3) 0.88 (3 H, d, J 7, 6-CH3), 1.27 (3 H, s, 1-CH3), 2.28 
(2 H, m, 5-H2), 2.67 (1 H, m, 6-H), 3.69 (3 H, s, 1-CO2CH3), 4.10 (2 H, s, 2-
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CH2) and 6.16 (1 H, s, 3-H); δH for 185 α (300 MHz, CDCl3) 0.96 (3 H, d, J, 
7, 6-CH3), 1.38 (3 H, s, 1-CH3), 2.28 (2 H, m, 5-H2), 2.67 (1 H, m, 6-H), 3.66 
(3 H, s, 1-CO2CH3), 4.18 (2 H, s, 2-CH2) and 6.18 (1 H, s, 3-H); δC (75 MHz, 
CDCl3) 15.9, 16.2, 16.9, 20.9, 36.8, 38.9, 41.8, 42.4, 49.8, 50.4, 52.6, 52.8, 
62.0, 63.0, 123.8, 125.6, 163.4, 166.1, 172.9, 175.0, 198.9 and 199.8; m/z 
(CI) 230 (M+ + 18, 38%), 214 (10), 213 (100). 
 
 
[(1SR,4SR,6RS)-1-Benzenesulfonylmethyl-4-(tert-butyl-diphenyl-
silanyloxy)-2-hydroxymethyl-1,6-dimethyl-2-cyclohexene (196).44 
 
 
 
 
Concentrated HCl (0.67 ml) was added to sulfone 187 (2.5 g; 4.7 mmol) in 
ethanol (78 ml) at room temperature and the reaction stirred until TLC 
indicated the complete consumption of the starting material (1 h). 
Aqueous saturated NaHCO3 (26 ml) was added and the aqueous phase 
was extracted with ether (4 x 35 ml). The organics were dried (MgSO4), 
filtered and concentrated under reduced pressure. Chromatography of the 
residue on silica gel eluting with ether - light petroleum (1 : 20 → 3 : 10) 
afforded the title compound 196 (1.92 g, 92%) as a white foam, Rf = 0.31 
(ether in light petroleum, 1:1); (found: M+ + Na, 571.2316. C32H40O4NaSSi 
requires M, 571. 2309); νmax/cm-1 3491, 2961, 2857, 2933, 1471, 1305, 1073, 
1046, 824 and 741; δH (500 MHz, CDCl3) 0.81 (3 H, d, J 6.6, 6-CH3), 0.89 (3 
H, s, 1-CH3), 0.97 [9 H, s, SiC(CH3)3], 1.40 (1 H, dt, J 13.0, 9.8, 5-H), 1.51 
(1 H, m, 5-H’), 2.34 (1 H, dqd, J 13.0, 6.6, 2.5, 6-H), 2.43 (1 H, br s, OH), 
3.07 (1 H, d, J 14.5, 1-CH), 3.50 (1 H, d, J 14.5, 1-CH’), 3.99 (1 H, d, J 12.6, 
2-CH), 4.05 (1 H, d, J 12.6, 2-CH’), 4.36 (1 H, m, 4-H), 5.76 (1 H, br s, 3-H), 
7.27-7.41 (8 H, m, Ar-H), 7.48-7.52 (1 H, m, Ar-H) and 7.58-7.60 (4 H, m, 
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Ar-H); δC (125 MHz, CDCl3) 16.2, 19.5, 21.8, 27.3, 33.2, 37.0, 42.0, 61.1, 
65.1, 68.9, 127.9, 127.9, 129.5, 130.0, 130.0, 133.8, 134.4, 134.7, 136.1 and 
141.7;  m/z (ES) 571 (M+ + 23, 100%). 
 
 
(1SR,4SR,6RS)-1-Benzenesulfonylmethyl-4-(tert-butyldiphenyl-
silanyloxy)-2-(tributylstannanylmethoxymethyl)-1,6-dimethyl-2-
cyclohexene (158).44 
 
 
 
 
NaH (0.232 g; 5.79 mmol) was added portion wise to alcohol 196 (2.12 g; 
3.9 mmol) in THF (30 ml) at room temperature and the resulting white 
suspension stirred for 15 minutes. Iodomethyltributyltin (1.73 ml; 5.75 
mmol) was added and the resulting white suspension stirred at room 
temperature overnight. Water (160 ml) was added and the aqueous phase 
was extracted with ether (2 x 200 ml). The organic phases were dried 
(MgSO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue on silica gel eluting with ether - light 
petroleum (0 : 1 → 1 : 5) afforded the title compound 158 (3.10g, 94%) as a 
clear colourless oil, Rf = 0.71 (ether in light petroleum, 1:1); (found: M+ + 
Na, 875.3522. C45H68O4NaSSiSn requires M, 875.3525); νmax/cm-1 3069, 
2955, 2855, 1462, 1446, 11427, 1375, 1362, 1319, 1150, 1110, 1084, 1059, 
823, 742, 702 and 689; δH (300 MHz, CDCl3) 0.85-0.95 (18 H, m, 6-CH3 and 
Sn(CH2)3(CH2)3(CH2)3(CH3)3), 1.09 [9 H, s, SiC(CH3)3], 1.14, (3 H, s, 1-
CH3), 1.28 (6 H, dq, J 14.3, 7.2, (CH2)3(CH2)3(CH3)3), 1.53-1.54 (6 H, m, 
(CH2)3(CH2)3(CH2)3), 1.61-1.70 (2 H, m, 5-H2), 2.46 (1 H, m, 6-H), 3.23 (1 H, 
d, J = 14.6, CHSnBu3), 3.40 (1 H, d, J 14.6, CH’SnBu3), 3.54 (1 H, d, J 
10.3, 1-CH), 3.69 (1 H, d, J 10.3, 1-CH’), 3.74 (1 H, d, J 12.2, 2-CH), 4.13 (1 
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H, d, J 12.2, 2-CH’), 4.38 (1 H, t, J 7.2, 4-H), 5.67 (1 H, d, J 1.6, 3-H), 7.37-
7.53, (9 H, m, Ar-H), 7.70-7.73 (4 H, m, Ar-H) and 7.84-7.87 (2 H, m, Ar-
H); δC (75 MHz, CDCl3) 9.1, 13.9, 16.5, 19.4, 21.9, 27.2, 27.5, 29.4, 33.3, 
36.6, 42.3, 61.1, 61.6, 68.3, 76.9, 77.3, 77.7, 79.2, 127.7, 127.8, 127.8, 129.4, 
129.8, 132.1, 133.6, 134.5, 134.7, 136.1, 136.1, 139.0 and 142.1; m/z (ES) 
875 (M+ + 23, 100%). 
 
(1RS,3SR,4RS,6SR)-3-Benzenesulfonylmethyl-6-(tert-
butyldiphenyl-silanyloxy)-1-hydroxymethyl-3,4-dimethyl-2-
methylene-cyclohexane (159).44 
 
 
 
n-BuLi (4.9 ml; 7.9 mmol) was added in a dropwise fashion down the 
inside wall of the reaction vessel to stannane 158 (3.0 g; 3.49 mmol) in dry 
THF (86) at -78 ºC. The resulting bright yellow solution was stirred for 30 
minutes before being warmed to -30 ºC and then stirred at this 
temperature overnight. Methanolic saturated NH4Cl (2.3 ml) was added 
and the solution warmed to room temperature before the addition of 
aqueous saturated NH4Cl (25 ml). The aqueous phase was extracted with 
ethyl acetate (5 x 30 ml) and the organics washed with brine (200 ml), 
dried (NaSO4), filtered and concentrated under reduced pressure. 
Chromatography of the crude product on silica gel eluting with ether – 
light petroleum (0 : 1 → 10 : 3) afforded the title compound 159 (1.19g, 
60%) as a white solid, Rf = 0.31 (ether in light petroleum, 3:5), mp 143-144 
ºC, (found: M++Na, 585.2465. C33H42O4NaSSi2 requires M, 585.2565); 
νmax/cm-1 3516, 3068, 2933, 2859, 1963, 1897, 1829, 1635,1588, 1469, 1449, 
1428, 1312, 1148, 1108, 1084, 739 and 703; δH (500 MHz, CDCl3) 0.85 [9 H, 
s, SiC(CH3)3], 0.95 (3 H, d, J 6.7, 4-CH3), 1.04 (3 H, s, 3-CH3), 1.24-1.34 (2 
H, m, 5-H2), 1.44 (1 H, m, 4-H), 2.37-2.42 (2 H, m, OH and 1-H), 3.10 (1 H, 
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d, J 15.3, 3-CH), 3.18 (1 H, d, J 15.3, 3-CH’), 3.48 (1 H, dt, J 8.6, 5.4, 6-H), 
3.61 (2 H, m, 1-CH2), 4.81 (1 H, s, 2-CH), 5.07 (1 H, s, 2-CH’), 7.17-7.20 (6 
H, m, Ar-H), 7.30-7.32 (2 H, m, Ar-H), 7.40 (1 H, dd, J 7.4, 7.3, Ar-H), 7.48-
7.51 (4 H, m, Ar-H) and 7.65 (2 H, d, J 7.0, Ar-H); δC (75 MHz, CDCl3) 
16.7, 19.5, 20.5, 27.2, 36.2, 38.9, 45.0, 50.6, 63.2, 73.7, 74.4, 111.7, 127.6, 
127.9, 128.1, 129.6, 130.0, 130.2, 133.6, 133.7, 134.4, 136.1, 136.1, 142.6 
and 148.7; m/z (ES) 585 (M+ + 23, 100%). 
 
(E)-2-Methyl-hept-2-en-6-ynoic acid ethyl ester (182). 
 
OEt
O
 
 
Dimethylsulfoxide (12.6 ml, 178.3 mmol) in dichloromethane (67.5 ml) was 
added to oxalyl chloride (7.8 ml, 89 mmol) in dichloromethane (168.7 ml) 
at -78 ºC in a dropwise fashion. The solution was stirred at this 
temperature for 20 minutes before the addition of 4-pentyne-1-ol 181 (5.5 
ml, 59.4 mmol) in dichloromethane (100 ml) in a dropwise fashion. The 
solution was stirred at -78 ºC for 1 hour before the addition of 
triethylamine (33 ml, 237.8 mmol) and warming to room temperature and 
stirred at this temperature for 1 hour. The solution was then cooled to -78 
ºC before the addition of the ylid (25.8 g; 71 mmol) in dichloromethane 
(67.5 ml). The resulting suspension was warmed to room temperature and 
stirred for 24 hours. Aqueous saturated NH4Cl (168 ml) was added to the 
reaction mixture and the organic phase washed with water (200 ml), brine 
(200 ml), dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue was dry loaded onto silica and purified 
chromatography eluting with ether – light petroleum (1 : 10) to give the 
title compound 182 (7.24 g, 73%) as a clear colourless oil, Rf = 0.72 (ether 
in light petroleum, 1:1), (found: M++NH4, 184.1330. C10H18O2N requires M, 
184.1332); νmax/cm-1 3299, 2981, 1710, 1651, 1445, 1389, 1368, 1313, 1271, 
1122, 1082, 1034, 868, 778 and 744; δH (300 MHz, CDCl3) 1.27 (3 H, t, J 
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7.2, 1-CO2CH2CH3), 1.83 (3 H, s, 2-CH3), 1.99 (1 H, t, J 2.5, 7-H), 2.29-2.45 
(4 H, m, 5-H2 and 6-H2), 4.18 (2 H, q, J 7.2, CO2CH2CH3) and 6.75 (1 H, td, 
J 6.9, 1, 3-H); δC (75 MHz, CDCl3) 12.7, 14.5, 18.0, 27.9, 60.7, 69.3, 83.4, 
129.5, 139.6 and 168.1; m/z (CI)184 (M+18, 100%). 
 
 
(E)-2-Methyl-hept-2-en-6-yn-1-ol (183). 
 
OH
 
 
 
DIBAL-H (1M in hexanes; 33.1 ml; 33.1 mmol) was added in a dropwise 
fashion to ester 182 (2.2 g; 13.2 mmol) in dichloromethane (73 ml) at -78 
ºC. The clear solution was stirred at -78 ºC for 1 hour before elevation to 
room temperature and continued stirring at this temperature for 2 hours. 
Methanol (4.4 ml) was added dropwise and the mixture was poured onto a 
stirring, saturated aqueous solution of Rochelle’s salt (116 ml) and diluted 
with dichloromethane (300 ml). The resulting biphasic mixture was stirred 
vigorously overnight before separation of the aqueous layer and extraction 
with dichloromethane (3 x 100 ml). The organics were dried (Na2SO4), 
filtered and concentrated under reduced pressure. Chromatography of the 
residue on silica gel eluting with ether - light petroleum (1 : 5) afforded the 
title compound 183 (1.1 g, 71%) as a clear colourless oil, Rf = 0.33 (ether in 
light petroleum, 1:1), (found: M++H, 124.0883. C8H12O requires M, 
124.0882); νmax/cm-1 3297, 2917, 2862, 1432, 1065, 1005 and 848; δH (300 
MHz, CDCl3) 1.69 (3 H, s, 2-CH3), 1.97 (1 H, t, J 2.5, 7-H), 2.1 (1 H, m, 
OH), 2.16-2.35 (4 H, m, 4-H2 and 5-H2), 3.98-4.06 (2 H, s, 1-H2) and 5.47 (1 
H, m, 3-H); δC (75 MHz, CDCl3) 14.0, 18.8, 26.9, 68.7, 68.7, 84.4, 123.9 and  
136.7; m/z (CI) 142 (M+ + 18, 100%). 
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(2E,6E)-7-Iodo-2,6-dimethylhepta-2,6-dien-1-ol (184) 
 
I OH  
 
 
Trimethylaluminium (2.0 M, 17.1 ml, 34.2 mmol) was added dropwise to 
Cl2ZrCp2 (1.7 g, 5.7 mmol) in dichloromethane (70.78 ml) at 0 ºC over 15 
min. The lemon yellow reaction mixture was then stirred at 0 ºC for 30 
min. To this was added alcohol 183 (1.4 g, 11.4 mmol) in dichloromethane 
(70.78 ml) and the solution allowed to warm to room temperature over an 
hour and stirred overnight. The reaction was cooled to -30 ºC before the 
addition of iodine (5.79 g, 22.8 mmol) in THF (38.3 ml) and then allowed to 
warm to room temperature over 1 hour. The reaction  was cooled to 0 ºC 
before adding water (10 ml), the aqueous phase was separated and the 
organic phase washed with aqueous saturated Na2S2O3 (40 ml), brine (40 
ml), dried (MgSO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue eluting with ether – light petroleum (2 : 5) 
afforded the title compound 184 (2.44 g, 80%) as a clear colourless oil, Rf = 
0.28 (ether in light petroleum, 1:1), (found: M++NH4, 284.0506. C9H19ONI 
requires M, 284.0506); νmax/cm-1 3331, 2914, 1443, 1376, 1268, 1141, 1010 
and 768; δH (500 MHz, CDCl3) 1.59 (3 H, d, J 1.0, 2-CH3), 1.78 (3 H, d, J 
1.0, 6-CH3), 2.09-2.14 (2 H, m, 4-H2), 2.20-2.16 (2 H, m, 5-H2), 3.92 (2 H, s, 
1-H), 5.28 (1 H, ddq, J = 8.5, 6.9, 1.0, 3-H) and 5.82 (1 H, q, J = 1.0, 7-H); 
δC (125 MHz, CDCl3) 11.8, 23.9, 25.9, 39.1, 68.7, 75.1, 124.5, 135.7 and 
147.5; m/z (CI) 284 (M+ + 18, 100%). 
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(2E,6E)-1-( tert-butyl-dimethyl-silyanyloxy)-7-iodo-2,6-dimethyl-
hepta-2,6-diene (161). 
 
I O
Si
 
 
 
Imidazole (4.68 g; 68.8 mmol) and tert-butyl-dimethylsilyl chloride (1.47 g; 
9.8 mmol) were added to alcohol 184 (1.74 g; 6.5 mmol) in dichloromethane 
(48 ml) at 0 ºC. The solution was stirred at room temperature for 24 hours 
before the addition of saturated aqueous NH4Cl (34 ml). The biphasic 
solution was extracted into ether (3 x 20 ml) and the organics were washed 
with brine (50 ml), dried (MgSO4), filtered and concentrated under 
reduced pressure. Chromatography of the residue on silica gel eluting with 
ether - light petroleum (3 : 10) afforded the title compound 161 (2.36 g, 
95%) as a clear colourless oil, Rf = 0.93 (ether in light petroleum, 1:1), 
(found: M++NH4, 398.1370. C15H33ONISi requires M, 398.1367); νmax/cm-1 
2952, 2929, 2855, 1464, 1253, 1110, 1070, 838 and 775; δH (500 MHz, 
CDCl3) 0.00 [6 H, s, Si(CH3)2], 0.85 [9 H, s, SiC(CH3)3], 1.53 (3 H, t, J 1.0, 
2-CH3), 1.78 (3 H, d, J 1.0, 6-CH3), 2.09-2.13 (2 H, m, 4-H2), 2.16-2.20 (2 H, 
m, 5-H2), 3.94, (2 H, s, 1-H), 5.27 (1 H, ddq, J 8.5, 6.9, 1.0, 3-H) and 5.82 (1 
H, q, J 1.0, 7-H); δC (125 MHz, CDCl3) -5.2, 13.5, 18.4, 23.9, 25.8, 26.0, 
39.2, 68.3, 75.0, 122.7, 135.3 and 147.6; m/z (ES) 398 (M+ + 18, 70%) 355 
(100). 
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(1SR,3SR,4RR,6SR)-3-Benzenesulfonylmethyl-6-(tert-
butyldiphenyl-silanyloxy)-3,4-dimethyl-2-
methylenecyclohexanecarbaldehyde (160).44 
 
 
 
 
Di-isopropylethylamine (0.204 ml, 1.14 mmol) was added to alcohol 159 
(146.0 mg, 0.256 mmol) in dichloromethane (0.97 ml) (0.24 ml) at room 
temperature. The solution was cooled to 0 ºC before the addition of Py.SO3 
(125.7 mg, 0.774 mmol) in dimethylsulfoxide (1.10 ml). The solution was 
stirred at 0 ºC until TLC indicated the complete consumption of the 
starting material (15 minutes). The reaction was poured onto stirring 
brine (5.0 ml) and the aqueous phase extracted with ethyl acetate (4 x 5 
ml). The organics were washed with saturated aqueous Cu(II)SO4 (20 ml), 
water (15 ml), brine (15 ml), dried (MgSO4), filtered and concentrated 
under reduced pressure. Chromatography of the residue on silica gel 
eluting with ether - light petroleum (1 : 1) afforded the title compound 160 
(138.0 mg, 95%) as a glassy white solid, Rf = 0.40 (ether in light petroleum, 
1:1), (found: M++Na, 583.2316. C33H40O4NaSSi requires M, 583.2309); 
νmax/cm-1 2959, 2934, 2858, 1728, 1448, 1315, 1149, 1109, 1042, 911, 824 
and 740; δH (500 MHz, CDCl3) 0.83 (3 H, d, J 7.0, 4-CH3), 0.94 [9 H, s, 
SiC(CH3)3], 1.16 (3 H, s, 3-CH3), 1.48 (1 H, dt, J 14.1, 9.0, 5-H), 1.67 (1 H, 
dt, J 14.1, 4.7, 5-H’), 1.95 (1 H, m, 4-H), 3.03 (1 H, dd , J 7.1, 3.1, 1-H), 3.12 
(1 H, d, J 14.8, 3-CH), 3.21 (1 H, d, J = 14.8, 3-CH’), 4.22 (1 H, ddd, J 12.5, 
7.8, 5.1, 6-H), 4.80 (1 H, s, 2-CH), 5.23 (1 H, s, 2-CH’), 7.28-7.39, (6 H, m, 
Ar-H), 7.40 (2 H, dd, J 8.2, 7.4, Ar-H), 7.53 (1 H, dd, J 7.5, 7.4, Ar-H), 7.56-
7.59 (4 H, m, Ar-H), 7.74 (2 H, d, J 7.4, Ar-H) and 9.32 (1 H, d, J 3.1, 1-
CHO); δC (125 MHz, CDCl3) 17.1, 19.4, 22.2, 27.2, 35.2, 36.9, 44.8, 62.6, 
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62.9, 69.6, 115.1, 127.7, 127.9, 128.1, 129.6, 130.1, 130.3, 133.7, 133.8, 
134.2, 136.1, 136.1, 142.4, 144.4 and 202.7; m/z (ES) 583 (M+ + 23, 100%). 
 
±(1’R,2’E,6’E)-8’-tert-butyldimethylsilyloxy-1-[(1R,3S,4R,6S)-6-tert-
butyldiphenylsilyloxy-3,4-dimethyl-2-methylene-3-
phenylsulfonylmethylcyclohexyl]-3’,7’-dimethylocta-2’,6’-dien-1’-ol 
(162)44 
 
 
 
t-BuLi (1.7 M in pentane; 1.97 ml, 3.34 mmol) was added dropwise to vinyl 
iodide 161 (1.27 g, 3.34 mmol) in THF (8.40 ml) at -78 ºC and stirred at 
this temperature for 1 hour. The resulting yellow solution was transferred 
via cannula to a solution of dry Yb(OTf)3 (2.07 g, 3.34 mmol) in THF (73.30 
ml) at -78 ºC. The resulting wine red solution was stirred at -78 ºC for 30 
minutes before transferring via cannula to aldehyde 67 (0.625 g, 1.11 
mmol) in THF (6.56 ml) at -78 ºC. After 5 hours, saturated methanolic 
ammonium chloride (40 ml) was added and allowed to room temperature 
before the addition of saturated aqueous solution of Rochelle’s salt (40 ml). 
The organic phase was separated and the aqueous phase extracted with 
EtOAc (4 x 30 ml). The organic phase was washed with brine (100 mL), 
dried (Na2SO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue on silica gel, eluting with ether-light 
petroleum (1:20 → 1:1) afforded the title compound 162 (0.690 g, 76%) as a 
white solid, Rf = 0.41 (1:1 ether in light petroleum), mp 96-98 ºC; νmax/cm-1 
3394, 2931, 2858, 2360, 2341, 1471, 1447, 1427, 1307, 1216, 1149, 1105, 
1084, 1049, 906, 836 and 730; δH (400MHz, CDCl3) 0.00 [6 H, s, Si(CH3)2], 
0.78 (3 H, d, J 6.8, 4-CH3), 0.85 [9 H, s, SiC(CH3)3], 0.99 [9 H, s, 
SiC(CH3)3], 1.29 (3 H, s, 7’-CH3), 1.38 (1 H, d, J  1.0, 3’-CH3), 1.49 (1 H, m, 
5-H), 1.52 (3 H, s, 3-CH3), 1.59 (1 H, m, 5-H’), 1.82-1.90 (3 H, m, 4-H and 
 137 
4’-H2), 1.93-1.98 (2 H, m, 5’-H2), 2.36 (1 H, dd , J  7.6, 6.3, 1-H), 2.42 (1 H, 
br s, 1’-OH), 2.95 (1 H, d, J 14.6, 3-CH), 3.26 (1 H, d, J 14.6, 3-CH’), 3.93 (2 
H, s, 8’-H2), 4.00 (1 H, m, 6-H), 4.28 (1 H, t, J 8.3, 1’-H), 4.83 (1 H, s, 2-
CH), 5.00 (1H, dd, J 8.8, 0.8, 2’-H), 5.12 (1 H, s, 2-CH’), 5.24 (1 H, td, J 6.6, 
1.5, 6’-H), 7.30-7.40 (6 H, m, Ar-H), 7.42-7.46 (2 H, m, Ar-H), 7.54 (1 H, m, 
Ar-H), 7.63-7.67 (4 H, m, Ar-H) and 7.77-7.79 (2 H, m, Ar-H); m/z (ES) 
838 (M+ + Na, 100%). 
 
 
±(1R,3R,4R,6S)-1-[(1’R,2’E,6’E)-1’-(trimethylsilylethoxymethoxy)-8’-
(tert-butyldimethylsilanyloxy)-3’,7’-dimethylocta-2’,6’-diene]-3-
benzenesulfonylmethyl-6-(tert-butyldiphenylsilanyloxy)-3,4-
dimethyl-2-methylenecyclohexane 202 
 
 
 
 
 
Di-isopropylethylamine (1.96 ml, 11.25 mmol), SEM-Cl (1.0 ml, 5.60 mmol) 
and TBAI (0.10 g, 0.26 mmol) were added to a solution of alcohol 162 (1.07 
g, 1.31 mmol) in dichloromethane (12.42 ml) at 0 °C and the solution 
stirred for 48 h at room temperature before the addition of water (18 ml). 
The aqueous was extracted with dichloromethane (3 x 20 ml) and the 
organic extracts washed with brine (20 ml), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Chromatography of the residue on 
silica gel, eluting with ether-light petroleum (1:10 → 2:8) afforded the title 
compound 202 (1.16 g, 94%) as a clear viscous oil, Rf = 0.61 (1:1 ether in 
light petroleum), (found: M++Na, 967.5189. C54H84O6NaSSi3 requires M, 
967.5189); νmax/cm-1 3070, 2928, 2856, 1667, 1627, 1589, 1472, 1447, 1319, 
1249, 1149, 1104, 1059 and 1038; δH (500 MHz, CDCl3) 0.00 [9 H, s, 
Si(CH3)3], 0.12 [6 H, s, Si(CH3)2], 0.77 (2 H, m, CH2Si), 0.97 [9 H, s, 
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SiC(CH3)3], 1.07 (3 H, s, 3’-CH3), 1.08 [9 H, s, SiC(CH3)3], 1.13 (3 H, d, J 
7.3, 4-CH3), 1.53 (3 H, s, 3-CH3), 1.62 (3 H, s, 7’-CH3), 1.65 (1 H, m, 5-H), 
1.87-2.02 (5 H, m, 5’-H2, 4’-H2, 5-H’), 2.62 (1 H, m, 4-H), 2.67 (2 H, m, 1-H, 
3-CH), 3.06 (1 H, td, J = 10.1, 6.3, OCHCH2Si), 3.24 (1 H, td, J = 10.1, 6.3, 
OCHCH2Si), 3.37 (1 H, d, J 14.2, 3-CH’), 4.04 (2 H, s, 8’-H2), 4.10 (1 H, t, J 
9.8, 1’-H), 4.17 (1 H, d, J 6.9, OCHO), 4.35 (1 H, m, 6-H), 4.36 (1 H, d, J 
6.9, OCH’O), 4.87 (1 H, d, J 9.8, 2’-H), 5.15 (1 H, s, 2-CH), 5.24 (1 H, s, 2-
CH’), 5.29 (1 H, t, J = 6.9, 6’-H), 7.35-7.48 (6 H, m, Ar-H), 7.55 (2 H, m, Ar-
H), 7.64 (1 H, m, Ar-H), 7.73 (4 H, dd, J 15.5, 7.3, Ar-H) and 7.89 (2 H, d, J 
7.9, Ar-H); δC (125 MHz, CDCl3) -3.9, 0.0, 14.9, 17.1, 19.6, 19.8, 19.9, 20.5, 
24.5, 27.3, 27.4, 28.4, 34.6, 35.0, 40.7, 45.1, 58.5, 65.2, 66.5, 70.0, 71.7, 
72.3, 91.6, 119.3, 124.5, 125.2, 128.5, 128.8, 128.9, 130.6, 130.7, 130.8, 
134.7, 135.6, 135.7, 136.2, 137.6, 142.0, 143.8 and 148.9; m/z (ES) 968 (M+ 
+ Na, 100%). 
 
±(1R,3S,4R,6S)-1-[(2’E,6’E,8’R)-8’-(trimethylsilylethoxymethoxy)-
2’,6’-dimethyl-octa-2’,6’-dien-1’-ol]-3-Benzenesulfonylmethyl-6-(tert-
butyldiphenyl-silanyloxy)-3,4-dimethyl-2-methylenecyclohexane 
203 
PhO2S
OTBDPS
H
OH
O
O
1'
8'
3
6
SiMe3
 
 
 
TBS ether 202 (400 mg, 0.42 mmol) was in acetic acid, water and THF (3 : 
1 : 1; 2.50 ml) was stirred at room temperature until TLC indicated the 
complete consumption of the starting material (2 days). Toluene (10 ml) 
was added and the mixture concentrated under reduced pressure. The 
residue was dissolved in toluene, dried (Na2SO4), filtered and concentrated 
under reduced pressure. Chromatography of the residue on silica gel, 
eluting with ether - light petroleum (1:1) afforded the title compound 203 
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(280 mg, 82%) as a clear oil, Rf = 0.19 (ether in light petroleum, 1:1), 
(found: M++Na, 853.4326. C48H70O6NaSSi2 requires M, 853.4324); νmax/cm-1 
3531, 2931, 2858, 1628, 1588, 1447, 1428, 1385, 1316, 1248, 1148, 1104, 
1039, 934 and 859; δH (400 MHz, CDCl3) 0.00 [9 H, s, Si(CH3)3], 0.77 (2 H, 
m, CH2Si), 1.04 (3 H, d, J 1.0, 6’-CH3), 1.08 [9 H, s, SiC(CH3)3], 1.13 (3 H, 
d, J 7.3, 4-CH3), 1.55 (3 H, s, 3-CH3), 1.63 (1 H, m, 5-H), 1.71 (3 H, s, 2’-
CH3), 1.87-1.96 (4 H, m, OH, 5’-H2 and 5-H), 1.98-2.09 (2 H, m, 4’-H2), 2.62 
(1 H, m, 4-H), 2.67 (1 H, d, J 9.0, 1-H), 2.72 (1 H, d, J 14.4, 3-CH), 3.07 (1 
H, td, J 9.8, 6.1, OCHCH2Si), 3.24 (1 H, td, J 9.8, 6.1, OCHCH2Si), 3.38 (1 
H, d, J 14.4, 3-CH’), 4.04 (2 H, s, 1’-H2), 4.08 (1 H, t, J 9.6, 8’-H), 4.17 (1 H, 
d, J 7.1, OCHO), 4.34 (1 H, m, 6-H), 4.35 (1 H, d, J 7.1, OCH’O), 4.90 (1 H, 
d, J 9.6, 7’-H), 5.17 (1 H, s, 2-CH), 5.26 (1 H, m, 3’-H), 5.28 (1 H, s, 2-CH’) 
7.35-7.48 (6 H, m, Ar-H), 7.55 (2 H, m, Ar-H), 7.65 (1 H, tt, J 7.3, 2.0, 1.3, 
Ar-H), 7.73 (4 H, m, Ar-H) and 7.88 (2 H, m, Ar-H); δC (100 MHz, CDCl3) 
0.0, 15.2, 16.8, 19.6, 19.8, 20.5, 24.4, 26.6, 28.4, 34.6, 35.1, 40.4, 45.1, 58.4, 
64.9, 66.6, 70.1, 71.9, 72.3, 91.6, 119.2, 125.0, 126.2, 128.5, 128.8, 128.9, 
130.6, 130.7, 130.8, 134.8, 135.5, 135.7, 137.0, 137.6, 141.6, 143.7 and 
149.0; m/z (ES) 854 (M+ + Na, 100%). 
 
±(1R,3S,4R,6S)-1-[(1’R,2’E,6’E)-1’-(trimethylsilylethoxymethoxy-8’-
bromo-3’,7’-dimethyl-octa-2’,6’-dienyl]-3-benzenesulfonylmethyl-6-
(tert-butyldiphenylsilanyloxy)-3,4-dimethyl-2-methylene-
cyclohexane 188 
 
 
 
Triethylamine (0.61 ml, 2.86 mmol) was added to the alcohol 203 (1.19 g, 
1.43 mmol) and MsCl (0.22 ml, 2.86 mmol) in THF (7.25 ml) at 0 ºC and 
the solution stirred at 0 ºC for 1 hour. Dried LiBr (0.504 g, 5.72 mmol) in 
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THF (5.40 ml) was added and the solution was stirred until TLC had 
indicated the complete consumption of the staring material (1.5 hours). 
The reaction was diluted with pentane (50 ml) and ice cold water (50 ml). 
The aqueous phase was extracted with pentane (3 x 50 ml) and the organic 
extracts were washed with saturated aqueous NaHCO3 solution (60 ml), 
brine (60 ml), dried (Na2SO4), filtered and concentrated under reduced 
pressure. Chromatography of the residue on silica gel, eluting with ether - 
light petroleum (3:10) afforded the title compound 188 (1.184 g, 93%) as a 
clear viscous oil, Rf = 0.52 (ether in light petroleum, 1:1); (found: M++Na, 
915.3508. C48H69O5BrNaSSi2 requires M, 915.3480); νmax/cm-1 2932, 2887, 
1663, 1628, 1588, 1447, 1428, 1386, 1318, 1248, 1149, 1104, 1086 and 
1037; δH (400 MHz, CDCl3) 0.00 [9 H, s, Si(CH3)3], 0.78 (2 H, m, CH2Si), 
1.08 [9 H, s, SiC(CH3)3], 1.10-1.12 (6 H, m, 3’-CH3 and 4-CH3), 1.52 (3 H, s, 
3-CH3), 1.63 (1 H, m, 5-H), 1.77 (3 H, d, J 1.3, 7’-CH3), 1.86-1.95 (3 H, m, 
4’-H2 and 5-H’), 1.96-2.06 (2 H, m, 5’-H2), 2.58 (1 H, m, 4-H), 2.67 (1 H, m, 
1-H), 2.69 (1 H, d, J 14.4, 3-CH), 3.07 (1 H, td, J 10.0, 6.2, OCHCH2Si), 
3.26 (1 H, td, J 10.0, 6.2, OCH’CH2Si), 3.34 (1 H, d, J 14.4, 3-CH’), 3.97-
4.02 (1 H, m, 8’-H2), 4.13 (1 H, t, J 9.5, 1’-H), 4.19 (1 H, d, J 7.0, OCHO), 
4.33 (1 H, m, 6-H), 4.35 (1 H, d, J 7.0, OCH’O), 4.89 (1 H, dd, J 9.8, 1.0, 2’-
H), 5.16 (1 H, s, 2-CH), 5.25 (1 H, s, 2-CH’), 5.49 (1 H, m, 6’-H), 7.35-7.48 
(6 H, m, Ar-H), 7.55 (2 H, m, Ar-H), 7.65 (1 H, m, Ar-H), 7.69-7.75 (4 H, m, 
Ar-H) and 7.89 (2 H, m, Ar-H); δC (100 MHz, CDCl3) 0.0, 16.1, 17.2, 19.6, 
19.8, 20.5, 24.4, 27.8, 28.4, 34.8, 35.1, 40.0, 42.8, 45.2, 58.2, 65.2, 66.5, 
71.7, 72.3, 91.7, 119.1, 125.0, 128.6, 128.8, 128.9, 130.6, 130.7, 130.8, 
131.7, 133.8, 134.8, 135.6, 135.7, 137.6, 141.3, 143.8 and 149.0; m/z (ES) 
917 [M+ + Na, 100% (81Br)], 915 [M+ + Na, 88% (79Br)]. 
 
*note from this point forward, proton data is given according to numbering 
in phomactin, not the name.  
 
 
 141 
±(4E,8E)-(1S,2S,10R,11R,12S,14R)-2-Benzenesulfonyl-10-
(trimethylsilyl)ethoxy)methoxy)-12-(tert-butyldiphenyl 
silanyloxy)-1,4,8,14-tetramethyl-15-methylene-
bicyclo[9.3.1]pentadeca-4,8-diene 174 
 
 
 
P = TBDPS 
 
NaHMDS (1M solution in THF, 3.40 ml, 3.40 mmol) was added to bromide 
188 (1.18 g, 1.12 mmol) in THF (22.27 ml) at 0 ºC over a period of 40 
minutes. The resulting rich yellow solution was stirred at 0 ºC until TLC 
had indicated the complete consumption of starting material (45 minutes). 
Aqueous saturated NH4Cl solution (50 ml) and ethyl acetate (50 ml) were 
added to the mixture. The aqueous phase was extracted with ethyl acetate 
(4 x 50 ml) and the organic extracts washed with brine (50 ml), dried 
(Na2SO4), filtered and concentrated under reduced pressure. 
Chromatography of the crude product on silica gel eluting with ether – 
light petroleum afforded the title compound 174 (0.875 g, 82%) as a white 
solid, Rf = 0.54 (ether in light petroleum, 1:1); (found: M+ + Na 835.4210. 
C48H68O5NaSSi2 requires M, 835.4218); δH (500 MHz, CDCl3) 0.0 [9 H, s, 
Si(CH3)3], 0.92 (3 H, d, J 7.3, 12-CH3), 0.98 (2 H, t, J 8.8, CH2Si), 1.08 [9 
H, s, SiC(CH3)3], 1.11 (3 H, s, 11-CH3), 1.32 (3 H, s, 8-CH3), 1.44 (1 H, m, 6-
H), 1.47 (3 H, s, 4-CH3), 1.70-1.81 (3 H, m, 5-H, 6-H’ and 13-H), 1.85 (1 H, 
m, 5-H’), 2.34 (2 H, m, 9-H2), 2.40-2.56 (1 H, dt, J 15.5, 8.8, 13-H’), 2.77 (1 
H, dq, J 14.8, 7.3, 12-H), 2.93 (1 H, t, J 3.6, 10-H), 3.17 (1 H, dd, J 11.8, 
1.8, 1-H), 3.53 (1 H, m, OCHCH2Si), 3.76-3.84 (2 H, m, 14-H and 
OCH’CH2Si), 3.89 (1 H, t, J 7.1, 7-H), 4.66 (1 H, d, J 6.9, OCHO), 4.69 (1 
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H, d, J 6.9, OCH’O), 4.82 (1 H, d, J 10.1, 3-H), 5.07 (1 H, d, J 2.0, 15-CH), 
5.14 (1 H, dd, J 10.1, 1.6, 2-H), 5.97 (1 H, d, J 2.0, 15-CH’), 7.37 (2 H, m, 
Ar-H), 7.42 (2 H, m, Ar-H), 7.45-7.54 (7 H, m, Ar-H), 7.77 (2 H, d, J 6.9, 
Ar-H) and 7.84 (2 H, d, J 6.9, Ar-H); δC (125 MHz, CDCl3) 0.0, 18.4, 18.5, 
19.6, 20.7, 22.2, 23.3, 24.0, 28.8, 36.0, 36.1, 38.4, 40.2, 50.7, 53.8, 63.2, 
66.6, 69.9, 73.9, 93.3, 120.4, 121.8, 126.4, 128.9, 128.9, 129.8, 130.0, 130.6, 
130.9, 134.4, 135.9, 136.8, 137.5, 137.6, 138.6, 142.0, 142.1 and 147.5; m/z 
(ES) 831, (M+ + 18, 100%), 836 (M+ + 23, 70%). 
 
±(4E,8E)-(1S,2S,10R,11S,12S,14R)-2-Benzenesulfonyl-10-
(trimethylsilylethoxymethoxy)-1,4,8,14-tetramethyl-15-methylene-
bicyclo[9.3.1]pentadeca-4,8-dien-12-ol 205 
 
 
 
 
TBAF (5.10 ml, 5.10 mmol) was added to macrocycle 174 (0.207 g, 0.255 
mmol) in THF (1.66 ml) at room temperature. The solution was stirred at 
35 °C overnight before the addition of water (4 ml). The aqueous phase 
was extracted with ethyl acetate (4 x 15 ml) and the organic extracts were 
washed with brine (30 ml), dried (Na2SO4), filtered and concentrated 
under reduced pressure. Chromatography of the residue on silica gel 
eluting with ether - light petroleum (1 : 5 → 1 : 1) afforded the title 
compound 205 (0.124 g, 85%) as a white foam, Rf = 0.20 (ether in light 
petroleum, 1:1), (found: M++Na, 597.3050. C32H50O5NaSSi requires M, 
597.3040); νmax/cm-1 3509, 2948, 1662, 1620, 1448, 1382, 1301, 1264, 1143, 
1085, 1021, 918,  836 and 733; δH (400 MHz, CDCl3) 0.00 [9 H, s, Si(CH3)3], 
0.92 (2 H, t, J 8.6, CH2Si), 1.08 (1 H, d, J 7.3, 12-CH3), 1.20 (3 H, s, 8-CH3), 
1.37 (1 H, m, 13-H), 1.41 (3 H, s, 11-CH3), 1.62 (3 H, d, J 1.0, 4-CH3), 1.66 
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(1 H, m, 6-H), 1.98-1.79 (3 H, m, 5-H2, 6-H’), 2.37-2.48 (2 H, m, 9-H2), 2.85-
2.91 (1 H, dq, J 12.4, 2.5, 2.3, 1-H), 3.10 (1 H, dq, J 15.0, 7.3, 12-H), 3.25-
3.17 (1 H, dt, J 15.0, 8.8, 13-H’), 3.33 (1 H, t, J 3.8, 10-H), 3.50 (1 H, m, 
OCHCH2Si), 3.72-3.61 (2 H, m, OCH’CH2Si and 14-H), 4.20 (1 H, t, J 7.4, 
7-H), 4.62 (1 H, d, J 6.8, OCHO), 4.65 (1 H, d, J 6.8, OCH’O), 4.88 (1 H, d, 
J 10.1, 3-H), 5.00 (1 H, dd, J 10.1, 2.3, 2-H), 5.13 (1 H, d, J 2.8, 15-CH), 
6.03 (1 H, d, J 2.3, 15-CH’), 7.43 (2 H, m, Ar-H), 7.52 (1 H, m, Ar-H) and 
7.80 (2 H, m Ar-H); δC (125 MHz, CDCl3) 0.0, 17.6, 18.8, 19.6, 23.4, 23.6, 
24.2, 35.7, 35.9, 40.2, 41.0, 50.9, 53.5, 64.1, 66.4, 66.9, 74.0, 93.8, 120.7, 
121.7, 126.3, 130.1, 130.1, 131.2, 134.6, 138.4, 142.0 and 147.3; m/z (ES) 
598, (M+ + Na, 100%). 
 
 
±(3E,7E)-(2R,10S,11S,12R)-10-Benzenesulfonyl-2-
(trimethylsilylethoxymethoxy)-4,8,11,12-tetramethyl-14-oxo-
bicyclo[9.3.1]pentadeca-1(15),3,7-triene-15-carbaldehyde 206 
 
 
 
 
 
NMO (466 mg; 3.975 mmol) was added to a suspension of alcohol 205 (457 
mg, 0.795 mmol) and powdered 4Å molecular sieves (457 mg) in 
dichloromethane (18.78 ml) at room temperature. To this was added TPAP 
(41.90 mg; 0.119 mmol) in dichloromethane (5.28 ml). After 1.5 hours the 
black reaction suspension was diluted with dichloromethane (25 ml) and 
filtered on a pad of Celite, the black residue on the Celite pad was washed 
with copious amounts of ether. The organics were washed with Na2S2O3 (2 
x 30 ml) and brine (30 ml) and the aqueous layer extracted with ether (3 x 
30 ml). The organics were dried (Na2SO4), filtered and concentrated under 
reduced pressure. Chromatography of the residue on silica gel, eluted with 
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40% ether – light petroleum afforded the title compound 206 (347 mg, 
74%) as a yellow gum, Rf = 0.39 (50% ether in petrol), (found: M++Na, 
609.2667. C32H46O6NaSSi requires M, 609.2677); νmax/cm-1 2949, 1693, 
1675, 1446, 1304, 1248, 1145, 1084 and 1020; δH (400 MHz, CDCl3); 0.00 [9 
H, s, Si(CH3)3], 0.53 (3 H, d, J 0.8, 8-CH3), 0.91 (2 H, m, CH2Si), 1.09 (3 H, 
d, J 7.0, 12-CH3), 1.45 (3 H, d, J 1.3, 4-CH3), 1.60 (3 H, s, 11-CH3), 1.80 (1 
H, m, 6-H), 1.9-2.0 (2 H, m, 5-H2), 2.05 (1 H, m, 6-H’), 2.50 (1 H, m, 9-H), 
2.50 (1 H, dd, J 19.7, 1.3, 13-H), 3.13-3.23 (2 H, m, 13-H’ and 9-H’), 3.45-
3.60 (3 H, m, 10-H and OCH2C), 3.69 (1 H, dqd, J = 19.7, 7.1, 1.3, 12-H), 
4.61 (1 H, d, J 6.8, OCHO), 4.62 (1 H, m, 7-H), 4.67 (1 H, d, J 6.8, OCH’O), 
5.02 (1 H, dd, J 9.6, 1.3, 3-H), 5.76 (1 H, d, J 9.6, 1, 2-H), 7.55 (2 H, m, Ar-
H), 7.61-7.65 (1 H, m, Ar-H), 7.86 (1 H, m, Ar-H), 7.89 (1 H, m, Ar-H) and 
10.64 (1 H, s, 15-CHO); δC (125 MHz, CDCl3); 0.0, 14.9, 17.1, 18.0, 19.5, 
22.5, 27.0, 36.8, 37.3, 39.5, 43.7, 47.7, 66.4, 66.9, 68.7, 94.3, 127.7, 130.4, 
130.8, 131.3, 132.6, 135.3, 139.5, 141.3, 148.6, 152.3, 198.8 and 199.2; m/z 
(ES) 609, (M+ + Na, 100%). 
 
±(4E,8E)-(2R,10S,11S,12R,14R)-10-Benzenesulfonyl-2-
(trimethylsilylethoxymethoxy)-15-hydroxymethyl-4,8,11,12-
tetramethyl-bicyclo[9.3.1]pentadeca-3,7,1-(15)-trien-14-ol 175 
 
 
 
 
DIBAL-H (1.0 M in DCM, 5.25 ml, 5.25 mmol) was added to keto-aldehyde 
206 (308 mg, 0.525 mmol) in dichloromethane (10.1 ml) at -78 ºC and the 
solution stirred at this temperature for 2 hours. Methanol (5 ml) was 
added at -78 ºC and the mixture stirred at this temperature for 10 minutes 
before elevation to room temperature. A 5% aqueous solution of Rochelle’s 
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salt (15 ml) and ethyl acetate (15 ml) was added and the resulting biphasic 
mixture was stirred until the layers separated. The mixture was diluted 
with water (20 ml) and the aqueous phase extracted with ethyl acetate (4 
x 20 ml). The organics were washed with brine (25 ml), dried (Na2SO4), 
filtered and concentrated under reduced pressure. Chromatography of the 
residue on silica gel eluting with ether – light petroleum (1 : 5 → 3 : 5) 
afforded the title compound 175 (204 mg, 66%) as a viscous clear oil, Rf = 
0.20 (ether in light petroleum, 3:5), (found: M+Na, 613.2979. 
C32H50O6NaSSi requires M, 613.2990); νmax/cm-1 3485, 2950, 2879, 1446, 
1388, 1297, 1249, 1145, 1083, 1023, 917, 859, 836 and 727; δH (400 MHz, 
CDCl3) 0.00 [9 H, s, Si(CH3)3], 0.72 (3 H, s, 8-CH3), 0.88-0.95 (2 H, m, 
CH2CH2Si), 0.98 (3 H, d, J = 7.1, 12-CH3), 1.56 (3 H, s, 4-CH3), 1.63 (3 H, s, 
11-CH3), 1.67 (1 H, m, 14-OH), 1.87 (1 H, m, 6-H), 2.03-2.12 (4 H, m, 5-H2 
and 13-H2), 2.14-2.26 (2 H, m, 9-H and 6-H’), 2.50 (1 H, d, J = 16.9, 9-H’), 
3.24 (1 H, qt, J = 7.1, 3.3, 12-H), 3.42-3.52 (1 H, qd, J = 9.9, 6.3, OCHCH2), 
3.58 (1 H, dd, J = 11.9, 1.5, 15-CH), 3.62-3.71 (2 H, m, 10-H, and 
OCHCH2), 3.99 (1 H, t, J = 11.9, 20-OH), 4.32 (1 H, m, 14-H), 4.64 (1 H, d, 
J = 7.1, OCHO), 4.66 (1 H, d, J = 7.1, OCH’O), 4.72 (1 H, d, J = 11.9, 15-
CH’), 4.78 (1 H, m, 7-H), 5.12 (1 H, d, J = 8.6, 2-H), 5.57 (1 H, dd, J = 8.6, 
1.1, 3-H), 7.51-7.55 (2 H, m, Ar-H), 7.58-7.62 (1 H, m, Ar-H) and 7.85-7.88 
(2 H, m, Ar-H); δC (100 MHz, CDCl3) 0.0, 15.2, 17.3, 17.7, 19.7, 20.7, 27.6, 
36.9, 38.1, 38.6, 40.5, 47.3, 61.9, 67.0, 67.5, 69.7, 74.4, 94.1, 126.8, 127.1, 
130.2, 130.6, 133.0, 134.9, 138.7, 141.8, 143.3 and 143.8; m/z (ES) 613 (M+ 
+ Na, 100%). 
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±[(2R,3E,7E,10S,11S,12R,14R)-14-acetoxy-4,8,11,12-tetramethyl-10-
(phenylsulfonyl)-2-(2-
trimethylsilylethoxymethoxybicyclo[9.3.1]pentadeca-1(15),3,7-
trien-15-yl)]methyl acetate 211 
 
 
 
 
Triethylamine (83 µl, 0.590 mmol), acetic anhydride (28 µl, 0.259 mmol) 
and DMAP (36.0 mg, 0.259 mmol) was added to diol 175 (35.0 mg, 0.059 
mmol) in dichloromethane (1.5 ml) at room temperature, was added 
triethylamine (83 µl, 0.590 mmol), acetic anhydride and the reaction 
allowed to stir overnight. The mixture was poured into sat. NaHCO3 (2.0 
ml) and extracted with ether (4 x 5 ml), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Chromatography of the residue on 
silica gel eluting with 20-60% ether in light petroleum (1 : 5 → 3 : 5) 
afforded the title compound 211 (32.0 mg, 81%) as a viscous oil, Rf = 0.48 
(80% ether in petrol), (found: M++Na, 697.3195. C36H54O8NaSSi requires 
M, 697.3201); νmax/cm-1 2951, 2915, 1739, 1445, 1375, 1300, 1223, 1148, 
1140, 1083 and 1018; δH (500 MHz, CDCl3) 0.0 [9 H, s, Si(CH3)3], 0.72 (3 H, 
s, 8-CH3), 0.87-0.92 (2 H, m, CH2SiMe3), 0.98 (3 H, d, J 6.9, 12-CH3), 1.52 
(3 H, s, 4-CH3), 1.54 (3 H, s, 11-CH3), 1.90 (1 H, m, 6-H), 1.96-2.06 (5 H, m, 
5-H2 and OAc), 2.07-2.15 (5 H, m, 13-H, 6-H’ and OAc), 2.34 (1 H, qd, J 
14.8, 9.1, 1.6, 13-H’), 2.57 (1 H, d, J 16.7, 9-H), 2.69 (1 H, dd, J 16.7, 6.6, 9-
H), 3.29 (1 H, m, 12-H), 3.49 (1 H, m, OCHCH2), 3.59 (1 H, m, OCHCH2), 
3.73 (1 H, br, d, J 6.3, 10-H), 4.53 (1 H, d, J 7.0, OCHO), 4.55 (1 H, d, J 
7.0, OCHO), 4.57 (1 H, d, J 9.1, 2-H), 4.80 (1 H, d, J 12.6, 15-CH), 4.89 (1 
H, m, 7-H), 4.99 (1 H, d, J 12.6, 15-CH’), 5.23 (1 H, d, J 9.1, 3-H), 5.48 (1 
H, t, J 7.9, 14-H), 7.55 (2 H, t, J 7.4, Ar-H), 7.62 (1 H, t, J 7.4, Ar-H) and 
 147 
7.86-7.89 (2 H, m, Ar-H); δC (125 MHz, CDCl3) 0.0, 14.8, 17.7, 17.9, 19.2, 
19.4, 22.6, 23.0, 27.2, 35.8, 36.6, 39.4, 40.1, 48.4, 64.2, 66.6, 68.0, 73.9, 
74.1, 93.4, 127.6, 127.7, 130.4, 130.6, 133.2, 135.0, 137.3, 141.5, 141.9, 
143.1, 171.5 and 171.8; m/z (ES) 697 (M+ + Na, 100%). 
 
±((2R,3E,7E,10S,11S,12R,14R)-14-acetoxy-2-hydroxy-4,8,11,12-
tetramethyl-10-(phenylsulfonyl)bicyclo[9.3.1]pentadeca-1(15),3,7-
trien-15-yl)methyl acetate 212 
 
 
 
MgBr2.OEt2 (6.20 mg, 0.240 mmol), NaHCO3 (2.05 mg, 0.240 mmol) and n-
BuSH (25.0 µl, 0.233 mmol) were added to SEM protected alcohol 211 
(10.0 mg, 0.015 mmol) in diethyl ether (0.150 ml) and stirred at room 
temperature over night. Water (1.0 ml) was added and the reaction 
extracted with ethyl acetate (4 x 4 ml). The organics were dried (Na2SO4), 
filtered and concentrated under reduced pressure. Chromatography of the 
residue on silica gel eluting with ether in light petroleum (1 : 5 → 7 : 10) 
afforded the title compound 212 (2.9 mg, 36%) as a clear oil, Rf = 0.28 (80% 
ether in petrol), (found: M++Na, 567.2404. C30H40O7NaS requires M, 
567.2387); νmax/cm-1 3438, 2951, 2915, 1742, 1439, 1343, 1237, 1138, 1140 
and 1015; δH (500 MHz, CDCl3) 0.70 (3 H, s, 8-CH3), 0.94 (3 H, d, J 6.9, 12-
CH3), 1.45 (3 H, s, 4-CH3), 1.47 (3 H, s, 11-CH3), 1.86 (1 H, m, 6-H), 1.95-
2.05 (6 H, m, 5-H2, 13-H and OAc), 2.07 (3 H, s, OAc’), 2.14 (1 H, m, 6-H’), 
2.26-2.35 (2 H, m, 13-H’, 9-H), 2.52 (1 H, d, J 16.7, 9-H’), 3.24 (1 H, m, 12-
H), 3.60 (1 H, d, J 7.6, 10-H), 4.58 (1 H, d, J 8.8, 2-H), 4.81 (1 H, d, J 12.6, 
15-CH), 4.84 (1 H, m, 7-H), 5.10 (1 H, d, J 12.6, 15-CH’), 5.30 (1 H, d, J 8.8, 
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3-H), 5.53 (1 H, t, J 8.2, 14-H), 7.49-7.52 (2 H, m, Ar-H), 7.57 (1 H, m Ar-
H), 7.81-7.82 (2 H, m, Ar-H); m/z (ES) 567 (M+ + Na, 100%). 
 
±((2S,3R,5R,11S,12S,13R,15R,E)-15-acetoxy-2-hydroxy-5,9,12,13-
tetramethyl-11-(phenylsulfonyl)-4-
oxatricyclo[10.3.1.03,5]hexadeca-1(16),8-dien-16-yl)methyl acetate 
213 
 
OH
PhO2S
OAc
AcO
O
 
 
VO(acac)2 (0.1 mg, 0.0004 mmol)(2.10 mg, 0.0079 mmol) and TBHP (21 µl, 
0.0117 mmol) [5.5 M in decane (20 µl) diluted in benzene (80 µl)] was 
added to alcohol 212 (5.0 mg, 0.009 mmol) in benzene (0.10 ml) at room 
temperature. The resulting wine red solution was stirred at room 
temperature for 35 minutes. An aqueous solution of Na2SO3 (0.5 ml) was 
added and the resulting biphasic mixture was stirred for 10 minutes. 
Ethyl acetate (5 ml) was added and washed with saturated aqueous 
NaHCO3 solution (2 ml). The aqueous phase was extracted with ethyl 
acetate (4 x 4 ml). The organics were washed with brine (5 ml), dried 
(Na2SO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue on silica gel eluting with ether in light 
petroleum (1 : 5 → 3 : 5) afforded the title compound 213 (2.8 mg, 55%) as 
a clear oil, Rf = 0.19 (80% ether in petrol); (found: M++Na, 583.2347. 
C30H40O8NaS requires M, 583.2336); δH (400 MHz, CDCl3) 0.76 (3 H, s, 8-
CH3), 0.92 (3 H, d, J 7.1, 12-CH3), 1.00 (1 H, m, 5-H), 1.10 (3 H, s, 4-CH3), 
1.36 (3 H, s, 11-CH3), 1.93-1.96 (4 H, m, 5-H’, OAc), 1.97-2.05 (2 H, m, 6-
H2), 2.08 (3 H, s, OAc), 2.12 (1 H, m, 13-H), 2.31 (1 H, m, 13-H’, 2-OH), 
2.53 (1 H, d, J 17.2, 9-H), 2.64 (1 H, dd, J 17.2, 6.3, 9-H’), 2.89 (1 H, d, J 
9.6, 3-H), 3.23 (1 H, m, 12-H), 3.57 (1 H, d, J 9.6, 2-H), 3.72 (1 H, m, 10-H), 
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4.87 (1 H, d, J 13.1, 15-CH), 4.95-5.03 (2 H, m, 7-H, 15-CH’), 5.48 (1 H, t, J 
7.9, 14-H), 7.48-7.52 (2 H, m, Ar-H), 7.59 (1 H, tt, J 7.3, 2.3, 1.3, 1.3, Ar-H), 
7.82-7.84 (2 H, m, Ar-H); m/z (ES) 583 (M+ + Na, 100%). 
 
±(2R,3E,7E,10S,11S,12R,14S)-4,8,11,12-tetramethyl-15-methylene-
10-(phenylsulfonyl)bicyclo[9.3.1]pentadeca-3,7-diene-2,14-diol 214 
 
 
 
TBAF (1.0 in THF, 0.246 ml, 0.246 mmol) was added to macrocyle 174 
(10.0 mg, 0.012 mmol) in THF (0.20 ml) and the reaction refluxed for 4 
days. Water (0.5 ml) was added and extracted with ethyl acetate (4 x 5 
ml). The organics were dried (Na2SO4), filtered and concentrated under 
reduced pressure. Chromatography of the residue on silica gel eluting with 
ethyl acetate : pentane (1 : 10 → 1 : 1) afforded the title compound 214 (3.2 
mg, 58%) as a clear oil, Rf = 0.52 (80% ether in petrol); νmax/cm-1 3445, 
3286, 2972, 2943, 2877, 1447, 1295, 1251, 1135, 1082, 1012, 926, 733 and 
720; δH (400 MHz, CDCl3) 1.03 (3 H, d, J 7.3, 12-CH3), 1.15 (3 H, s, 8-CH3), 
1.26 (1 H, d, J 6.8, 14-OH), 1.31 (1 H, m, 13-H), 1.34 (3 H, s, 11-CH3), 1.45 
(1 H, d, J 2.3, 2-OH), 1.55 (3 H, d, J 1.1, 4-CH3), 1.61 (1 H, m, 6-H), 1.75 (1 
H, m, 6-H’), 1.80-1.93 (2 H, m, 5-H2), 2.37 (2 H, m, 9-H2), 2.75 (1 H, ddd, J 
11.6, 2.8, 2.5, 1-H), 2.96-3.09 (2 H, m, 12-H, 13-H’), 3.24 (1 H, t, J 4.0, 10-
H), 3.60 (1 H, m, 14-H), 4.13 (1 H, t, J 7.5, 7-H), 4.94 (1 H, dd, J = 9.8, 1.1, 
3-H), 5.01 (1 H, dt, J 9.8, 2.3, 2-H), 5.08 (1 H, d, J 2.5, 15-CH), 6.07 (1 H, d, 
J 2.3, 15-CH’), 7.35-7.39 (2 H, m, Ar-H), 7.46 (1 H, tt, J 7.4, 2.0, 1.3, 1.3, 
Ar-H), 7.72-7.76 (2 H, m, Ar-H); m/z (ES) 467 (M+ + Na, 100%), 479 (M‾ + 
Cl, 100%). 
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±(1S,2S,3R,5R,11S,12S,13R,15S,E)-5,9,12,13-tetramethyl-16-
methylene-11-(phenylsulfonyl)-4-oxatricyclo[10.3.1.03,5]hexadec-8-
ene-2,15-diol 215 
 
OH
PhO2S
OH
O
 
 
VO(acac)2 (2.10 mg, 0.0079 mmol) and TBHP (5.5 M in decane, 17.3 µl, 
0.095 mmol) was added to diol 214 (35.0 mg; 0.079 mmol) in benzene (0.73 
ml) at room temperature. The resulting wine red solution was stirred at 
room temperature for 30 minutes at which point TBHP (5.5 M in decane, 
28.8 µl, 0.158 mmol) was added and the reaction stirred for a further 1 h. 
An aqueous solution of Na2SO3 (1 ml) was added and the resulting 
biphasic mixture was stirred for 10 minutes. Ethyl acetate (10 ml) was 
added and washed with saturated aqueous NaHCO3 solution (5 ml) and 
the aqueous phase extracted with ethyl acetate (4 x 10 ml). The organics 
were washed with brine (10 ml), dried (Na2SO4), filtered and concentrated 
under reduced pressure. Chromatography of the residue on silica gel 
eluting with ethyl acetate : pentane (1 : 5 → 3 : 5) afforded the title 
compound 215 (27 mg, 75%) as a white solid, Rf = 0.34 (80% ether in 
petrol); (found: M++Na, 483.2173. C26H36O5NaS requires M, 483.2176); 
νmax/cm-1 3440, 2932, 1447, 1387, 1302, 1140, 1084, 1023, 911, 851 and 
803; δH (500 MHz, CDCl3) 0.90 (1 H, td, J = 13.1, 5.5, 5-H), 1.11 (3 H, d, J 
= 7.0, 12-CH3), 1.20 (3 H, s, 8-CH3), 1.24 (3 H, s, 4-CH3), 1.25-1.29 (1 H, m, 
13-H), 1.34 (3 H, s, 11-CH3), 1.72-1.82 (1 H, m, 6-H), 1.88-1.97 (2 H, m, 5-H 
and 6-H’), 2.20 (1 H, dt, J 14.2, 5.7, 13-H’), 2.35 (1 H, d, J 17.7, 9-H), 2.52-
2.60 (2 H, m, 1-H and 9-H’), 2.76 (1 H, dq, J 12.6, 7.0, 12-H), 2.85 (1 H, d, J 
4.6, 3-H), 3.21 (1 H, dd, J 4.8, 3.0, 10-H), 3.67 (1 H, dd, J 8.1, 4.6, 2-H), 
4.00 (1 H, q, J 7.0, 14-H), 4.55 (1 H, t, J 7.9, 7-H), 5.20 (1 H, s, 15-CH), 
5.58 (1 H, s, 15-CH’), 7.44 (2 H, t, J 7.5, Ar-H), 7.62 (1 H, m, Ar-H) and 
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7.78-7.81 (2 H, d, J 7.5, Ar-H); δC (125 MHz, CDCl3) 15.5, 16.5, 19.5, 20.9, 
23.4, 34.3, 34.9, 37.6, 37.8, 49.1, 57.7, 61.8, 63.0, 65.2, 67.4, 68.8, 122.2, 
122.3, 128.7, 128.9, 131.6, 133.4, 141.3 and 146.3; m/z (ES) 483 (M+ + Na, 
100%). 
 
±(2S,3R,5R,11S,12S,13R,15S,E)-15-(tert-butyldimethylsilyloxy)-
5,9,12,13-tetramethyl-16-methylene-11-(phenylsulfonyl)-4-
oxatricyclo[10.3.1.03,5]hexadec-8-en-2-ol 216 
 
 
 
 
Imidazole (16.0 mg, 0.235 mmol) and TBS-Cl (17.7 mg, 0.117 mmol) was 
added to diol 215 in dichloromethane (0.38 ml) and the reaction stirred at 
room temperature for 21 hours. Aqueous NaHCO3 (5 ml) was added and 
aqueous phase extracted with ethyl acetate (4 x 10 ml). The organics were 
dried (Na2SO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue using pentane : ethyl acetate (9:1 → 4:1) 
as eluent gave the title compound  216 as a clear oil (20.7 mg, 92 %), Rf = 
0.65 (50% ether in petrol); (found: M+Cl‾, 609.2842. C32H50O5SSiCl 
requires M, 609.2793); νmax/cm-1 3479, 2928, 2852, 1446, 1387, 1303, 1256, 
1146, 1099, 1073 and 1048; δH (400 MHz, CDCl3) 0.00 (3 H, s SiCH3), 0.01 
(3 H, s, SiCH3), 0.84 [9 H, s, Si(CH3)3], 1.08 (3 H, d, J 7.3, 12-CH3), 1.13 (1 
H, m, 5-H), 1.18 (1 H, m, 13-H), 1.34 (3 H, s, 4-CH3), 1.38 (3 H, s, 11-CH3), 
1.51-1.58 (4 H, m, 8-CH3, 13-H’), 2.06-2.11 (2 H, m, 5-H’, 6-H), 2.21 (1 H, 
m, 6-H’), 2.39 (1 H, d, J 11.7, 1-H), 2.42-2.48 (2 H, m, 9-H, OH), 2.70 (1 H, 
m, 12-H), 3.02 (1 H, dd, J 17.2, 4.5, 9-H’), 3.07 (1 H, d, J 1.0, 3-H), 3.32 (1 
H, dd, J 11.7, 4.8, 2-H), 3.46 (1 H, dd, J 5.5, 1.9, 10-H), 4.43 (1 H, m, 14-H), 
4.88 (1 H, dd, J 10.0, 5.4, 7-H), 5.32 (2 H, s, 15-CH2), 7.55-7.59 (2 H, m, Ar-
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H), 7.65 (1 H, m, Ar-H), 7.91-7.93 (2 H, m, Ar-H); δC (100 MHz, CDCl3) -
4.7, -4.6, 14.9, 15.6, 17.9, 19.5, 20.0, 24.5, 25.8, 32.5, 33.8, 35.8, 37.6, 49.2, 
61.1, 62.5, 63.5, 66.7, 68.5, 123.7, 126.8, 128.6, 129.2, 132.0, 133.4, 142.6, 
145.8; m/z (ES) 597 (M+ + Na, 100%), 609 (M + Cl‾, 100%). 
 
±(2S,3R,5R,11S,12S,13R,15S,E)-2-(benzyloxy)-5,9,12,13-tetramethyl-
16-methylene-11-(phenylsulfonyl)-4-
oxatricyclo[10.3.1.03,5]hexadec-8-en-15-yloxy)tert-
butyldimethylsilane 178 
 
 
 
KHMDS (1.0 M in THF, 0.14 ml, 0.14 mmol) and benzyl bromide (41.5 µl, 
0.35 mmol) was added to alcohol 216 (20.0 mg, 0.035 mmol) in THF (3.80 
ml) at -78 °C. The resulting bright yellow solution was then allowed to 
warm to room temperature before adding tetrabutyl ammonium iodide 
(13.1 mg, 0.035 mmol) and allowed to stir at this temperature for 16 
hours. Saturated aqueous NaHCO3 (5 ml) was added and the aqueous 
phase extracted with ethyl acetate (4 x 10 ml). The organics were dried 
(Na2SO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue using pentane - ethyl acetate (1:0 → 5:1) 
as eluent gave the title compound 178 (22.0 mg, 95 %) as a glassy white 
solid, Rf = 0.29 (light petroleum : ethyl acetate, 5:1); (found: M+ + Na, 
687.3502. C39H56O5NaSSi requires M, 687.3510); δH (500 MHz, CDCl3) 0.00 
(3 H, s SiCH3), 0.10 (3 H, s, SiCH3), 0.80 [9 H, s, Si(CH3)3], 0.80-0.85 (1 H, 
m, 5-H), 1.00 (3 H, d, J 7.3, 12-CH3), 1.11 (3 H, s, 8-CH3), 1.21 (3 H, s, 4-
CH3), 1.35 (3 H, s, 11-CH3), 1.54-1.58 (1 H, dd, J 13.9, 6.6, 13-H), 1.58-1.66 
(1 H, m, 6-H), 1.84 (1 H, ddd, J 12.9, 4.7, 2.8, 2.5, 5-H’), 1.90-1.96 (1 H, m, 
6-H’), 2.29-2.33 (1 H, m, 9-H), 2.35-2.39 (1 H, d, J 18.6, 9-H’), 2.86-2.92 (2 
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H, m, 12-H and 13-H’), 2.94 (1 H, d, J 9.1, 3-H), 3.02 (1 H, dq, J 12.3, 2.8, 
2.5, 2.2, 1-H), 3.34 (1 H, t, J 4.1, 10-H), 3.78 (1 H, dd, J 9.1, 2.2, 2-H), 3.88- 
3.94 (1 H, m, 14-H), 4.52 (1H, d, J 11.9, PhCH), 4.55 (1 H, t, J 7.6, 7-H), 
4.68 (1 H, d, J 11.9, PhCH’), 5.10 (1 H, d, J 2.8, 15-CH), 6.10 (1 H, d, J 2.5, 
15-CH’), 7.15 (1 H, m, Ar-H), 7.22 (2 H, m, Ar-H), 7.26 (2 H, m, Ar-H), 7.40 
(2 H, m, Ar-H), 7.48 (1 H, m, Ar-H), 7.73 (2 H, m, Ar-H); δC (125 MHz, 
CDCl3) -2.0, 0.0, 18.7, 19.0, 19.9, 23.4, 23.9, 24.4, 27.9, 36.1, 36.4, 40.4, 
40.4, 50.5, 51.7, 61.7, 64.6, 65.7, 68.5, 74.3, 80.5, 121.2, 128.8, 129.0, 129.8, 
130.1, 130.4, 133.2, 134.9, 140.8. 142.4 and 147.1; m/z (ES) 687 (M+ + Na, 
100%). 
 
±(2S,3R,5R,11S,12S,13R,15S,E)-2-(benzyloxy)-5,9,12,13-tetramethyl-
16-methylene-11-(phenylsulfonyl)-4-
oxatricyclo[10.3.1.03,5]hexadec-8-en-15-ol 217 
 
 
 
 
TBAF (1.0 M in THF, 0.316 ml, 0.316 mmol) was added to TBS ether 178 
(21.0 mg, 0.032 mmol) in THF (165 µl) at room temperature. Saturated 
aqueous NaHCO3 (3 ml) was added after 16 hours and then extracted with 
ethyl acetate (4 x 10 ml). The organics were dried (Na2SO4), filtered and 
concentrated under reduced pressure. Chromatography of the residue 
using pentane - ethyl acetate (3 : 2) as eluent gave the title compound 217 
(14.3 mg, 82 %) as a clear oil, Rf = 0.31 (light petroleum : ethyl acetate, 
1:1); (found: M+ + Na, 573.2644. C33H42O5NaS requires M, 573.2645); δH 
(500 MHz, CDCl3) 0.89 (1 H, td, J  13.3, 5.5, 5-H), 1.01 (4 H, d, J 7.1, 12-
CH3, 14-OH), 1.12 (3 H, s, 8-CH3), 1.23 (3 H, s, 4-CH3), 1.29 (1 H, dd, J 
13.8, 6.9, 13-H), 1.38 (3 H, s, 11-CH3), 1.61 (1 H, m, 6-H), 1.84 (1 H, ddd, J 
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13.3, 4.7, 2.8, 5-H’), 1.91 (1 H, m, 6-H’), 2.34 (2 H, m, 9-H2), 2.27 (1 H, dq, J 
12.9, 2.8, 1-H), 2.90 (1 H, d, J 9.1, 3-H), 3.06-3.16 (2 H, m, 12-H, 13-H’), 
3.36 (1 H, t, J 3.8, 10-H), 3.75 (1 H, m, 14-H), 3.84 (1 H, dd, J 9.1, 2.5, 2-
H), 4.53 (1 H, d, J 12.0, PhCH), 4.54 (1 H, m, 7-H), 4.77 (1 H, d, J 12.0, 
PhCH’), 5.12 (1 H, d, J 3.2, 15-CH), 6.20 (1 H, d, J 2.8, 15-CH’), 7.18 (1 H, 
m, Ar-H), 7.23-7.30 (4 H, m, Ar-H), 7.39-7.42 (2 H, m, Ar-H), 7.48 (1 H, m, 
Ar-H), 7.75-7.72 (2 H, m, Ar-H); δC (125 MHz, CDCl3) 16.7, 17.4, 22.1, 22.6, 
22.7, 34.1, 34.5, 38.7, 40.2, 49.0, 49.8, 59.9, 62.9, 63.7, 65.0, 72.9, 78.3, 
119.0, 119.9, 127.4, 127.6, 128.2, 128.5, 128.8, 132.1, 133.3, 139.2, 140.6 
and 145.2; m/z (ES) 573 (M+ + Na, 100%), 549 (M¯ - H, 40%), 595 (M¯ + Cl, 
100%). 
 
 
±(2S,3R,5R,11S,12S,13R,E)-2-(benzyloxy)-5,9,12,13-tetramethyl-15-
oxo-11-(phenylsulfonyl)-4-oxatricyclo[10.3.1.03,5]hexadeca-1(16),8-
diene-16-carbaldehyde 218 
 
 
 
 
Powdered 4 Å molecular sieves (12.0 mg) and N-Methylmorpholine-N-
oxide (15.0 mg, 0.088 mmol) were added to alcohol 217 (14.0 mg, 0.025 
mmol) in dichloromethane (0.61 ml). TPAP (1.5 mg, 0.004 mmol) in 
dichloromethane (0.15 ml) was then added and the reaction stirred at 
room temperature. After 1.5 hours the black reaction suspension was 
diluted with dichloromethane (5 ml) and filtered on a pad of Celite, the 
black residue on the Celite pad was washed with copious amounts of 
ether. The organics were washed with Na2S2O3 (2 x 5 ml), brine (5 ml) and 
the aqueous layer extracted with ether (2 x 10 ml). The combined organics 
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were dried (Na2SO4), filtered and concentrated under reduced pressure. 
Chromatography of the residue using pentane - ethyl acetate (7 : 3) as 
eluent gave the title compound 218 (10.9 mg, 76 %) as a yellow gum, Rf = 
0.54 (light petroleum : ethyl acetate, 1:1); (found: M+ + Na, 585.2281. 
C33H38O6NaS requires M, 585.2281); δH (500 MHz, CDCl3) 0.70 (3 H, s, 8-
CH3), 0.91 (1 H, m, 5-H), 1.06-1.08 (6 H, m, 4-CH3, 12-CH3), 1.56 (3 H, s, 
11-CH3), 1.83-1.87 (2 H, m, 5-H’, 6-H), 1.90 (1 H, dt, J 13.2, 3.6, 6-H’), 2.42 
(2 H, m, 9-H2), 2.62 (1 H, d, J 8.9, 3-H), 3.05-3.16 (2 H, m, 10-H, 13-H), 
3.54 (1 H, d, J 6.3, 13-H’), 3.62 (1 H, dq, J 12.9, 6.9, 12-H), 4.44 (1 H, d, J 
11.7, PhCH), 4.49 (1 H, d, J 8.9, 2-H), 4.63 (1 H, d, J 11.7, PhCH’), 4.66 (1 
H, t, J 8.2, 7-H), 7.19-7.27 (5 H, m, Ar-H), 7.47-7.50 (2 H, t, J 7.7, Ar-H), 
7.57 (1 H, t, J 7.3, Ar-H), 7.81 (2 H, d, J 7.3, Ar-H), 10.52 (1 H, s, 15-CHO); 
δC (125 MHz, CDCl3) 14.5, 16.3, 16.8, 20.3, 24.1, 34.9, 36.2, 38.2, 42.4, 47.0, 
59.4, 64.4, 67.4, 72.3, 74.2, 123.8, 127.6, 127.9, 128.4, 128.9, 129.3, 131.8, 
134.0, 137.5, 139.6, 139.6, 153.9, 196.9 and 197.2; m/z (ES) 585 (M+ + Na, 
100%), 561 (M¯ , 100%). 
 
±(2S,3R,5R,11S,12S,13R,15R,E)-2-(benzyloxy)-16-(hydroxymethyl)-
5,9,12,13-tetramethyl-11-(phenylsulfonyl)-4-
oxatricyclo[10.3.1.03,5]hexadeca-1(16),8-dien-15-ol 179 
 
O
PhO2S
O
HO
OH
 
 
DIBAL-H (1.0 M in DCM, 0.18 ml, 0.18 mmol) was added to ketoaldehyde 
218 (10.0 mg, 0.018 mmol) (308 mg, 0.525 mmol) in dichloromethane (0.35 
ml) at -78 ºC. The reaction was stirred at -60 ºC for 1.5 hours before 
lowering the temperature back to -78 ºC and adding methanol (1 ml); the 
mixture was stirred at this temperature for 10 minutes before elevation to 
 156 
room temperature. A 5% aqueous solution of Rochelle’s salt (5 ml) and 
ethyl acetate (5 ml) was added and the resulting biphasic mixture was 
stirred until the layers separated. The mixture was diluted with water (5 
ml) and the aqueous phase extracted with ethyl acetate (4 x 5 ml). The 
organics were washed with brine (5 ml), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Chromatography of the residue on 
silica gel eluting with pentane - ethyl acetate (7 : 3 → 4 : 6) afforded the 
title compound 179 (4.2 mg, 42%) as a clear oil, Rf = 0.25 (ether in light 
petroleum, 1:1), (found: M+ + Na, 589.2574. C33H42O6NaS requires M, 
589.2594); δH (500 MHz, CDCl3) 0.81 (3 H, s, 8-CH3), 0.93 (3 H, d, J 7.0), 
0.99 (1 H, m, 5-H), 1.15 (3 H, s, 4-CH3), 1.28 (1 H, d, J 5.0, 14-OH), 1.59 (3 
H, s, 11-CH3), 1.91-1.98 (4 H, m, 5-H’, 6-H2 and 13-H), 2.10 (1 H, m, 13-H’), 
2.16 (1 H, dd, J 17.7, 6.9, 9-H), 2.43 (1 H, d, J 17.7, 9-H’), 3.14 (1 H, m, 12-
H), 3.23 (1 H, d, J 9.1, 3-H), 3.47 ( 1 H, dd, J 11.5, 2.0, 15-CH), 3.73 (1 H, 
m, 10-H), 3.89 (1 H, d, J 9.1, 2-H), 3.94 (1 H, t, J 11.5, 15-CH2OH), 4.05 (1 
H, m, 14-H), 4.51-4.54 (2 H, m, 15-CH’, OCHPh), 4.85 (1 H, d, J 11.7, 
OCH’Ph), 4.90 (1 H, m, 7-H), 7.21-7.29 (5 H, m, Ar-H), 7.45-7.48 (2 H, m, 
Ar-H), 7.54 (1 H, m, Ar-H), 7.79-7.80 (2 H, m, Ar-H); m/z (ES) 589 (M+ + 
Na, 100%). 
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